BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-30. [PMID: 10188901 DOI: 10.1038/sj.bjc.6690243] [Cited by in Crossref: 937] [Cited by in F6Publishing: 836] [Article Influence: 42.6] [Reference Citation Analysis]
Number Citing Articles
1 Gervasoni JE, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am. 2000;80:1631-1673. [PMID: 11140865 DOI: 10.1016/s0039-6109(05)70253-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
2 Pata G, Solaini L, Roncali S, Pasini M, Ragni F. Total gastrectomy with “over-D1” lymph node dissection: what is the actual impact of age? The American Journal of Surgery 2012;204:732-40. [DOI: 10.1016/j.amjsurg.2012.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Klink CD, Binnebösel M, Schneider M, Ophoff K, Schumpelick V, Jansen M. Operative outcome of colon interposition in the treatment of esophageal cancer: a 20-year experience. Surgery 2010;147:491-6. [PMID: 20004440 DOI: 10.1016/j.surg.2009.10.045] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
4 Gunderson LL, Donohue JH, Alberts SR. Cancer of the Stomach. Abeloff's Clinical Oncology. Elsevier; 2008. pp. 1431-64. [DOI: 10.1016/b978-0-443-06694-8.50083-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Marubini E, Bozzetti F, Miceli R, Bonfanti G, Gennari L. Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. Eur J Surg Oncol. 2002;28:406-412. [PMID: 12099651 DOI: 10.1053/ejso.2001.1247] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
6 Galizia G, Lieto E, De Vita F, Castellano P, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, De Sena G, De Stefano L. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surgery. 2015;157:285-296. [PMID: 25532433 DOI: 10.1016/j.surg.2014.09.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
7 Degiuli M, Calvo F. Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary? World J Surg. 2006;30:2193-2203. [PMID: 17103096 DOI: 10.1007/s00268-006-0179-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
8 Moehler M, Baltin CTH, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer H, Palmqvist A, Röcken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wittekind C, Wagner D, Mönig SP. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer 2015;18:550-63. [DOI: 10.1007/s10120-014-0403-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
9 Vallbohmer D, Oh DS, Peters JH. The role of lymphadenectomy in the surgical treatment of esophageal and gastric cancer. Curr Probl Surg 2012;49:471-515. [PMID: 22793506 DOI: 10.1067/j.cpsurg.2012.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Higuchi K, Phan A, Ajani JA. Gastric cancer: advances in adjuvant and adjunct therapy. Curr Treat Options Oncol. 2003;4:413-419. [PMID: 12941201 DOI: 10.1007/s11864-003-0042-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Cady B. Sentinel lymph node procedure in squamous cell carcinoma of the vulva. J Clin Oncol 2000;18:2795-7. [PMID: 10920125 DOI: 10.1200/JCO.2000.18.15.2795] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kung CH, Tsai JA, Lundell L, Johansson J, Nilsson M, Lindblad M. Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery. BJS Open 2020;4:424-31. [PMID: 32129948 DOI: 10.1002/bjs5.50270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Hennequin C, Quero L, Mineur L. Cancer de l’estomac : doses et volumes-cibles. Cancer/Radiothérapie 2008;12:659-62. [DOI: 10.1016/j.canrad.2008.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Chua YJ, Cunningham D. The UK NCRI MAGIC Trial of Perioperative Chemotherapy in Resectable Gastric Cancer: Implications for Clinical Practice. Ann Surg Oncol 2007;14:2687-90. [DOI: 10.1245/s10434-007-9423-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
15 Toiyama Y, Yasuda H, Ohi M, Yoshiyama S, Araki T, Tanaka K, Inoue Y, Mohri Y, Kusunoki M. Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent. The American Journal of Surgery 2017;213:120-6. [DOI: 10.1016/j.amjsurg.2016.05.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
16 Kung CH, Lindblad M, Nilsson M, Rouvelas I, Kumagai K, Lundell L, Tsai JA. Postoperative pancreatic fistula formation according to ISGPF criteria after D2 gastrectomy in Western patients. Gastric Cancer. 2014;17:571-577. [PMID: 24105422 DOI: 10.1007/s10120-013-0307-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
17 Eom BW, Joo J, Kim YW, Reim D, Park JY, Yoon HM, Ryu KW, Lee JY, Kook MC. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer. Surgery. 2014;155:408-416. [PMID: 24287148 DOI: 10.1016/j.surg.2013.08.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
18 Park DJ, Lee HJ, Kim HH, Yang HK, Lee KU, Choe KJ. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg. 2005;92:1099-1102. [PMID: 15931657 DOI: 10.1002/bjs.4952] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 11.4] [Reference Citation Analysis]
19 Chong G, Tebbutt NC. Perioperative therapy for resectable gastric cancer: what does the future hold? Asia Pac J Clin Oncol 2011;7:93-5. [PMID: 21585687 DOI: 10.1111/j.1743-7563.2011.01386.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Deng JY, Liang H, Sun D, Zhan HJ, Zhang RP. Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol 2008; 14(15): 2440-2447 [PMID: 18416477 DOI: 10.3748/wjg.14.2440] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
21 Gallo A, Cha C. Updates on esophageal and gastric cancers. World J Gastroenterol 2006; 12(20): 3237-3242 [PMID: 16718845 DOI: 10.3748/wjg.v12.i20.3237] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
22 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
23 Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004;90:1727-32. [PMID: 15150592 DOI: 10.1038/sj.bjc.6601761] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 7.7] [Reference Citation Analysis]
24 Pareekutty NM, Kadam S, Ankalkoti B, Balasubramanian S, Anilkumar B. Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India. Indian J Surg Oncol 2020;11:256-62. [PMID: 32523272 DOI: 10.1007/s13193-020-01059-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H, Akiyama H. Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach. Surgery. 2005;137:165-171. [PMID: 15674196 DOI: 10.1016/j.surg.2004.06.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
26 Slagter AE, Vollebergh MA, Jansen EPM, van Sandick JW, Cats A, van Grieken NCT, Verheij M. Towards Personalization in the Curative Treatment of Gastric Cancer. Front Oncol. 2020;10:614907. [PMID: 33330111 DOI: 10.3389/fonc.2020.614907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Jaworski R, Bollschweiler E, Holscher AH, Monig SP, Skokowski J, Zielinski J, Swierblewski M, Kopacz A, Jaskiewicz J. Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany. Gastric Cancer 2011;14:234-41. [PMID: 21442179 DOI: 10.1007/s10120-011-0036-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Martínez-Lago N, Vieito-Villar M, Vidal-Insua Y, Padin-Iruegas ME, Vazquez-Rivera F, Candamio-Folgar S, Lopez-Lopez R. Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction. Clin Transl Oncol 2015;17:856-61. [PMID: 26133519 DOI: 10.1007/s12094-015-1314-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303-308. [PMID: 15028313 DOI: 10.1016/j.ejso.2003.11.020] [Cited by in Crossref: 181] [Cited by in F6Publishing: 162] [Article Influence: 10.6] [Reference Citation Analysis]
30 Biffi R, Botteri E, Cenciarelli S, Luca F, Pozzi S, Valvo M, Sonzogni A, Chiappa A, Leal Ghezzi T, Rotmensz N, Bagnardi V, Andreoni B. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. European Journal of Surgical Oncology (EJSO) 2011;37:305-11. [DOI: 10.1016/j.ejso.2011.01.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
31 Jiang N, Deng JY, Ding XW, Ke B, Liu N, Liang H. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer. J Surg Res 2014;192:90-7. [PMID: 24953988 DOI: 10.1016/j.jss.2014.05.053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
32 Chipponi J, Huguier M, Pezet D, Basso N, Hay JM, Quandalle P, Jaeck D, Fagniez PL, Gainant A. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg. 2004;187:440-445. [PMID: 15006580 DOI: 10.1016/j.amjsurg.2003.12.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
33 Moehler M, Schimanski CC, Gockel I, Junginger T, Galle PR. (Neo)adjuvant strategies of advanced gastric carcinoma: time for a change? Dig Dis 2004;22:345-50. [PMID: 15812158 DOI: 10.1159/000083597] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
34 Menges M, Hoehler T. Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward. Gastrointest Tumors 2014;1:99-104. [PMID: 26675677 DOI: 10.1159/000362577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Hwang SH, Kim HI, Song JS, Lee MH, Kwon SJ, Kim MG. The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System. J Gastric Cancer 2016;16:207-14. [PMID: 28053806 DOI: 10.5230/jgc.2016.16.4.207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Pramesh C, Kulkarni NN, Mistry RC, Badwe RA. Lymphadenectomy in cancer: time for a paradigm shift? The Lancet Oncology 2006;7:450-1. [DOI: 10.1016/s1470-2045(06)70706-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Labianca R, Sburlati P, Quadri A, Garassino M. Perioperative or postoperative therapy for resectable gastric cancer? Annals of Oncology 2008;19:v99-v102. [DOI: 10.1093/annonc/mdn320] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
38 Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036. [PMID: 28569272 DOI: 10.1038/nrdp.2017.36] [Cited by in Crossref: 178] [Cited by in F6Publishing: 185] [Article Influence: 44.5] [Reference Citation Analysis]
39 Özer İ, Bostancı EB, Ulaş M, Özoğul Y, Akoğlu M. Changing Trends in Gastric Cancer Surgery. Balkan Med J 2017;34:10-20. [PMID: 28251018 DOI: 10.4274/balkanmedj.2015.1461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Hundahl SA. Evidence-based recommendations for local-regional control of gastric cancer. Cancer Invest 2005;23:352-62. [PMID: 16100947 DOI: 10.1081/cnv-58885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Wohnrath DR, Araujo RLC. D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival. Eur J Surg Oncol 2019;45:446-53. [PMID: 30392746 DOI: 10.1016/j.ejso.2018.10.538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
42 Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW, Choi SH, Sohn TS, Kim S, Noh JH. Postoperative chemoradiotherapy for gastric cancer. Ann Oncol. 2003;14:1373-1377. [PMID: 12954575 DOI: 10.1093/annonc/mdg366] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
43 Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One. 2012;7:e49424. [PMID: 23166665 DOI: 10.1371/journal.pone.0049424.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Ozmen M, Zulfikaroglu B, Kece C, Aslar A, Ozalp N, Koc M. Factors Influencing Mortality in Spontaneous Gastric Tumour Perforations. J Int Med Res 2002;30:180-4. [DOI: 10.1177/147323000203000211] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
45 Macalindong SS, Kim KH, Nam BH, Ryu KW, Kubo N, Kim JY, Eom BW, Yoon HM, Kook MC, Choi IJ, Kim YW. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center. BMC Cancer. 2018;18:73. [PMID: 29329569 DOI: 10.1186/s12885-017-3872-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
46 Lin GT, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Huang CM. Lymph Node Noncompliance Affects the Long-Term Prognosis of Patients with Gastric Cancer after Laparoscopic Total Gastrectomy. J Gastrointest Surg 2020;24:540-50. [PMID: 30937713 DOI: 10.1007/s11605-019-04199-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
47 Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
48 Kang JH, Ryu SY, Jung MR, Jeong O. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching. Eur J Surg Oncol 2020;46:1239-46. [PMID: 32331983 DOI: 10.1016/j.ejso.2020.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol 2014; 20(14): 3967-3975 [PMID: 24744586 DOI: 10.3748/wjg.v20.i14.3967] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 80] [Article Influence: 11.4] [Reference Citation Analysis]
50 Yao JC, Mansfield PF, Pisters PW, Feig BW, Janjan NA, Crane C, Ajani JA. Combined-modality therapy for gastric cancer. Semin Surg Oncol. 2003;21:223-227. [PMID: 14648779 DOI: 10.1002/ssu.10040] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
51 Elmessiry MM, El-Fayoumi TA, Fayed HM, Gebaly AA, Mohamed EAE. Operative and Oncological Outcomes After D2 Versus D1 Gastrectomy of Operable Gastric Cancer: an Observational Study. J Gastrointest Cancer 2020. [PMID: 33188500 DOI: 10.1007/s12029-020-00548-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kusano T, Shiraishi N, Shiroshita H, Etoh T, Inomata M, Kitano S. Poor prognosis of advanced gastric cancer with metastatic suprapancreatic lymph nodes. Ann Surg Oncol. 2013;20:2290-2295. [PMID: 23299769 DOI: 10.1245/s10434-012-2839-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
53 Jensen EH, Tuttle TM. Preoperative Staging and Postoperative Surveillance for Gastric Cancer. Surgical Oncology Clinics of North America 2007;16:329-42. [DOI: 10.1016/j.soc.2007.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
54 Baek SK, Kim SY, Jeong JH, Cho KS, Yoon HJ. Second-line chemotherapy for advanced gastric cancer in Korea. Gastric Cancer 2012;15:345-54. [PMID: 22410800 DOI: 10.1007/s10120-011-0114-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
55 Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol. 2007;14:2010-2017. [PMID: 17342569 DOI: 10.1245/s10434-006-9198-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
56 Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B, Parmentier G, Hay JM, Flamant Y, Msika S. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol. 2008;34:1246-1252. [PMID: 18222622 DOI: 10.1016/j.ejso.2007.12.003] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
57 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
58 Deng J, Zhang R, Pan Y, Wang B, Wu L, Hao X, Liang H. N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy. Tumour Biol 2014;35:3269-81. [PMID: 24293375 DOI: 10.1007/s13277-013-1428-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
59 Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, García Gómez de Las Heras S, Fernández Aceñero MJ. Pathologic Lymph Node Staging of Gastric Cancer. Am J Clin Pathol 2021:aqab031. [PMID: 34273159 DOI: 10.1093/ajcp/aqab031] [Reference Citation Analysis]
60 Jain VK, Cunningham D, Rao S. Chemotherapy for operable gastric cancer: current perspectives. Indian J Surg Oncol. 2011;2:334-342. [PMID: 23204792 DOI: 10.1007/s13193-012-0139-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
61 Lehnert T, Buhl K, Dueck M, Hinz U, Herfarth C. Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol. 2000;26:780-784. [PMID: 11087645 DOI: 10.1053/ejso.2000.1003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
62 Jin P, Liu H, Ma FH, Ma S, Li Y, Xiong JP, Kang WZ, Hu HT, Tian YT. Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion . World J Clin Cases 2021; 9(29): 8718-8728 [PMID: 34734050 DOI: 10.12998/wjcc.v9.i29.8718] [Reference Citation Analysis]
63 Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol. 2006;17:1404-1411. [PMID: 16788003 DOI: 10.1093/annonc/mdl133] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
64 Ibrahim M, Gilbert K. Management of gastric cancer in Indian population. Transl Gastroenterol Hepatol 2017;2:64. [PMID: 28905005 DOI: 10.21037/tgh.2017.07.02] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
65 Jain VK, Cunningham D, Chau I. Preoperative and Postoperative Chemotherapy for Gastric Cancer. Surgical Oncology Clinics of North America 2012;21:99-112. [DOI: 10.1016/j.soc.2011.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
66 Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, Ponzano C. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: Five-year results of a randomized prospective trial. Ann Surg. 2005;241:232-237. [PMID: 15650632 DOI: 10.1097/01.sla.0000151892.35922.f2] [Cited by in Crossref: 632] [Cited by in F6Publishing: 554] [Article Influence: 39.5] [Reference Citation Analysis]
67 Kasakura Y, Mochizuki F, Wakabayashi K, Kochi M, Fujii M, Takayama T. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res. 2002;103:252-259. [PMID: 11922742 DOI: 10.1006/jsre.2002.6368] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
68 Biondi A, D'ugo D, Cananzi F, Papa V, Borasi A, Sicoli F, Degiuli M, Doglietto G, Persiani R. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? European Journal of Surgical Oncology (EJSO) 2015;41:779-86. [DOI: 10.1016/j.ejso.2015.03.227] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
69 Yu W, Yun YK, Whang I, Choi GS. The surgeon's expertise-outcome relationship in gastric cancer surgery. Cancer Res Treat 2005;37:143-7. [PMID: 19956495 DOI: 10.4143/crt.2005.37.3.143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
70 Quéro L, Guillerm S, Hennequin C. Neoadjuvant or adjuvant therapy for gastric cancer. World J Gastrointest Oncol 2015; 7(8): 102-110 [PMID: 26306142 DOI: 10.4251/wjgo.v7.i8.102] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
71 Bruixola G, Segura Á, Díaz-Beveridge R, Caballero J, Bennis MH, Palomar L, Giménez A, Mingol F, García-Mora C, Aparicio J. Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution. Tumori 2015;101:517-23. [PMID: 26045120 DOI: 10.5301/tj.5000344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
72 Fukunaga T, Hiki N, Kubota T, Nunobe S, Tokunaga M, Nohara K, Sano T, Yamaguchi T. Oncologic Outcomes of Laparoscopy-Assisted Distal Gastrectomy for Gastric Cancer. Ann Surg Oncol 2013;20:2676-82. [DOI: 10.1245/s10434-013-2930-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
73 McCulloch P. The role of surgery in patients with advanced gastric cancer. Best Pract Res Clin Gastroenterol. 2006;20:767-787. [PMID: 16997159 DOI: 10.1016/j.bpg.2006.03.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
74 Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Multivariate prognostic study on large gastric cancer. J Surg Oncol. 2007;96:14-18. [PMID: 17582596 DOI: 10.1002/jso.20631] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
75 Watanabe M, Kinoshita T, Enomoto N, Shibasaki H, Nishida T. Clinical Significance of Splenic Hilar Dissection with Splenectomy in Advanced Proximal Gastric Cancer: An Analysis at a Single Institution in Japan. World J Surg 2016;40:1165-71. [DOI: 10.1007/s00268-015-3362-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
76 Pedrazzani C, Marrelli D, Rampone B, De Stefano A, Corso G, Fotia G, Pinto E, Roviello F. Postoperative Complications and Functional Results After Subtotal Gastrectomy with Billroth II Reconstruction for Primary Gastric Cancer. Dig Dis Sci 2007;52:1757-63. [DOI: 10.1007/s10620-006-9655-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
77 Soon YY, Leong CN, Tey JC, Tham IW, Lu JJ. Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis. J Med Imaging Radiat Oncol 2014;58:483-96. [PMID: 24995607 DOI: 10.1111/1754-9485.12190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
78 Allum WH; European Union Network of Excellence (EUNE) for Gastric Cancer Steering Group. Gastric cancer in Europe. British Journal of Surgery 2008;95:406-8. [DOI: 10.1002/bjs.6197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
79 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
80 Natarajan S, Taneja C, Cady B. Evolution of Lymphadenectomy in Surgical Oncology. Surgical Oncology Clinics of North America 2005;14:447-59. [DOI: 10.1016/j.soc.2005.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
81 Tokunaga M, Hiki N, Fukunaga T, Ohyama S, Yamaguchi T, Nakajima T. Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol. 2009;16:3245-3251. [PMID: 19636624 DOI: 10.1245/s10434-009-0645-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
82 Grau JJ, Palmero R, Marmol M, Domingo-Domenech J, Monzo M, Fuster J, Vidal O, Fondevila C, Garcia-Valdecasas JC. Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy. World J Surg Oncol. 2006;4:53. [PMID: 16904003 DOI: 10.1186/1477-7819-4-53] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
83 Claassen YHM, de Steur WO, Hartgrink HH, Dikken JL, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Kranenbarg WMM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH. Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial. Ann Surg. 2018;268:1008-1013. [PMID: 28817437 DOI: 10.1097/sla.0000000000002444] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
84 Leong T, Michael M, Foo K, Thompson A, Lim Joon D, Weih L, Ngan S, Thomas R, Zalcberg J. Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation. Br J Cancer. 2003;89:1433-1438. [PMID: 14562013 DOI: 10.1038/sj.bjc.6601311] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
85 Ang SD. Gastric cancer surgery: can east meet west? J Surg Oncol 2010;102:736. [PMID: 21105085 DOI: 10.1002/jso.21739] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Hu Y, McMurry TL, Goudreau B, Leick KM, Le TM, Zaydfudim VM. Comparative Effectiveness of Lymphadenectomy Strategies During Curative Resection for Gastric Adenocarcinoma. J Gastrointest Surg 2020;24:2212-8. [PMID: 31515762 DOI: 10.1007/s11605-019-04393-9] [Reference Citation Analysis]
87 Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell. 2004;5:121-125. [PMID: 14998488 DOI: 10.1016/s1535-6108(04)00033-9] [Cited by in Crossref: 201] [Cited by in F6Publishing: 100] [Article Influence: 11.8] [Reference Citation Analysis]
88 Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol. 2009;99:199-206. [PMID: 19142901 DOI: 10.1002/jso.21224] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
89 Yamamoto M, Rashid OM, Wong J. Surgical management of gastric cancer: the East vs. West perspective. J Gastrointest Oncol. 2015;6:79-88. [PMID: 25642341 DOI: 10.3978/j.issn.2078-6891.2014.097] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
90 Diaz-Nieto R, Orti-Rodríguez R, Winslet M. Post-surgical chemotherapy versus surgery alone for resectable gastric cancer. Cochrane Database Syst Rev. 2013;9:CD008415. [PMID: 23999923 DOI: 10.1002/14651858.cd008415.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
91 Mueller JL, Kim DH, Stapleton S, Cauley CE, Chang DC, Park CH, Song KY, Mullen JT. Nature versus nurture: the impact of nativity and site of treatment on survival for gastric cancer. Gastric Cancer 2019;22:446-55. [PMID: 30167904 DOI: 10.1007/s10120-018-0869-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
92 Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, Schleicher J, Vanhoefer U, Jehle E, Oechsle K, Trarbach T, Boehlke I, Kanz L, Hartmann J, Bokemeyer C. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. Annals of Oncology 2005;16:1326-33. [DOI: 10.1093/annonc/mdi252] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
93 Fotia G, Marrelli D, De Stefano A, Pinto E, Roviello F. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer. Eur J Surg Oncol. 2004;30:930-934. [PMID: 15498636 DOI: 10.1016/j.ejso.2004.07.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
94 Russell MC, Mansfield PF. Surgical approaches to gastric cancer. J Surg Oncol. 2013;107:250-258. [PMID: 22674546 DOI: 10.1002/jso.23180] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
95 Dikken JL, Stiekema J, van de Velde CJ, Verheij M, Cats A, Wouters MW, van Sandick JW. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol 2013;20:381-98. [PMID: 23054104 DOI: 10.1245/s10434-012-2574-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
96 Nitti D, Mocellin S, Marchet A, Pilati P, Lise M. Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am 2008;17:467-83, vii. [PMID: 18486878 DOI: 10.1016/j.soc.2008.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
97 Lustosa SA, Saconato H, Atallah AN, Lopes Filho Gde J, Matos D. Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials. Acta Cir Bras. 2008;23:520-530. [PMID: 19030751 DOI: 10.1590/s0102-86502008000600009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
98 Chan WL, Lam KO, Lee VHF, Davidson M, So TH, Li JS, Chau I, Kwong DLW. Gastric Cancer - From Aetiology to Management: Differences Between the East and the West. Clin Oncol (R Coll Radiol). 2019;31:570-577. [PMID: 31178345 DOI: 10.1016/j.clon.2019.05.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
99 Deng J, Liang H. D2 lymphadenectomy in gastric cancer surgery. Clin Oncol Cancer Res 2009;6:162-8. [DOI: 10.1007/s11805-009-0162-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Symeonidis D, Tepetes K. Techniques and Current Role of Sentinel Lymph Node (SLN) Concept in Gastric Cancer Surgery. Front Surg. 2018;5:77. [PMID: 30723718 DOI: 10.3389/fsurg.2018.00077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
101 Kim SM, Cho J, Kang D, Oh SJ, Kim AR, Sohn TS, Noh JH, Kim S. A Randomized Controlled Trial of Vagus Nerve-preserving Distal Gastrectomy Versus Conventional Distal Gastrectomy for Postoperative Quality of Life in Early Stage Gastric Cancer Patients. Ann Surg 2016;263:1079-84. [PMID: 26727095 DOI: 10.1097/SLA.0000000000001565] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
102 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
103 Portanova M, Vargas F, Lombardi E, Mena V, Carbajal R, Palacios N, Orrego J. Results of specialization in the surgical treatment of gastric cancer in Peru. Gastric Cancer 2007;10:92-7. [DOI: 10.1007/s10120-007-0413-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
104 Machin D. On the evolution of statistical methods as applied to clinical trials. J Intern Med 2004;255:521-8. [DOI: 10.1111/j.1365-2796.2004.01319.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
105 Shin K, Park SJ, Lee J, Park CH, Song KY, Lee HH, Seo HS, Jung YJ, Park JM, Lee SH, Roh SY, Kim IH. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. BMC Cancer 2019;19:1232. [PMID: 31852475 DOI: 10.1186/s12885-019-6433-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
106 Dittmar Y, Schüle S, Koch A, Rauchfuss F, Scheuerlein H, Settmacher U. Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer—a European single-centre experience. Langenbecks Arch Surg 2015;400:27-35. [DOI: 10.1007/s00423-014-1226-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
107 Rajdev L. Treatment options for surgically resectable gastric cancer. Curr Treat Options Oncol. 2010;11:14-23. [PMID: 20358316 DOI: 10.1007/s11864-010-0117-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
108 Goodman KA. Refining the Role for Adjuvant Radiotherapy in Gastric Cancer: Risk Stratification Is Key. J Clin Oncol 2015;33:3082-4. [PMID: 25559799 DOI: 10.1200/JCO.2014.59.1941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
109 Hundahl SA. Surgical quality in trials of adjuvant cancer therapy. J Surg Oncol 2002;80:177-80. [DOI: 10.1002/jso.10123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
110 Jiang Y, Kimchi ET, Montero AJ, Staveley-O’Carroll KF, Ajani JA. Upper gastrointestinal tumors: current status and future perspectives. Expert Rev Anticancer Ther. 2008;8:975-991. [PMID: 18533807 DOI: 10.1586/14737140.8.6.975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
111 Fukunaga S, Nagami Y, Shiba M, Ominami M, Tanigawa T, Yamagami H, Tanaka H, Muguruma K, Watanabe T, Tominaga K, Fujiwara Y, Ohira M, Hirakawa K, Arakawa T. Long-term prognosis of expanded-indication differentiated-type early gastric cancer treated with endoscopic submucosal dissection or surgery using propensity score analysis. Gastrointest Endosc. 2017;85:143-152. [PMID: 27365265 DOI: 10.1016/j.gie.2016.06.049] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 11.6] [Reference Citation Analysis]
112 Seulin P, Carrère N, Bloom E, Pradère B, Tap G, Gouzi JL. [Stomach cancer: have changes in surgical strategy influenced the results? 20-year retrospective study]. Ann Chir 2000;125:131-6. [PMID: 10998798 DOI: 10.1016/s0001-4001(00)00118-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, Cai MY. The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer 2015;15:370. [PMID: 25947284 DOI: 10.1186/s12885-015-1370-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
114 Brar S, Law C, McLeod R, Helyer L, Swallow C, Paszat L, Seevaratnam R, Cardoso R, Dixon M, Mahar A. Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg. 2013;217:347-57.e1. [PMID: 23664139 DOI: 10.1016/j.jamcollsurg.2013.01.067] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
115 Bremers AJ, Rutgers EJ, van de Velde CJ. Cancer surgery: the last 25 years. Cancer Treat Rev. 1999;25:333-353. [PMID: 10644500 DOI: 10.1053/ctrv.1999.0147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
116 Hawkes E, Chau I, Ilson DH, Cunningham D. Upper Gastrointestinal Malignancies: A New Era in Clinical Colorectal Cancer. Clinical Colorectal Cancer 2009;8:185-9. [DOI: 10.3816/ccc.2009.n.030] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
117 Marrelli D, Roviello F, De Stefano A, Fotia G, Giliberto C, Garosi L, Pinto E. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. Journal of the American College of Surgeons 2004;198:51-8. [DOI: 10.1016/j.jamcollsurg.2003.08.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
118 Murphy PM, Blackshaw GR, Paris HJ, Edwards P, Barry JD, Lewis WG. Prospective evaluation of nutritional status related to body mass indices and outcomes after modified D2 gastrectomy for carcinoma. Clin Nutr. 2004;23:477-483. [PMID: 15297082 DOI: 10.1016/j.clnu.2003.07.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
119 El-Sedfy A, Dixon M, Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn NG. Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy. Ann Surg Oncol. 2015;22:1820-1827. [PMID: 25348779 DOI: 10.1245/s10434-014-4168-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
120 Wu CW, Chiou JM, Ko FS, Lo SS, Chen JH, Lui WY, Whang-Peng J. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 2008;98:54-9. [PMID: 18182977 DOI: 10.1038/sj.bjc.6604097] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
121 Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol. 2006;24:2188-2196. [PMID: 16682738 DOI: 10.1200/jco.2006.05.9758] [Cited by in Crossref: 138] [Cited by in F6Publishing: 63] [Article Influence: 9.2] [Reference Citation Analysis]
122 Zhao Y, Yu P, Hao Y, Qian F, Tang B, Shi Y, Luo H, Zhang Y. Comparison of outcomes for laparoscopically assisted and open radical distal gastrectomy with lymphadenectomy for advanced gastric cancer. Surg Endosc 2011;25:2960-6. [DOI: 10.1007/s00464-011-1652-y] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
123 Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg. 2000;87:1006-1015. [PMID: 10931042 DOI: 10.1046/j.1365-2168.2000.01538.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 3.5] [Reference Citation Analysis]
124 Nelson R, Ko EB, Arrington A, Lee W, Kim J, Garcia-Aguilar J, Kim J. Race and correlations between lymph node number and survival for patients with gastric cancer. J Gastrointest Surg. 2013;17:471-481. [PMID: 23288716 DOI: 10.1007/s11605-012-2125-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
125 Chittawadagi B, Nayak SK, Ramakrishnan P, Kumar S, Cumar B, Natarajan R, Palanivelu PR, Chinnusamy P. Laparoscopic D2 gastrectomy in advanced gastric cancer: Postoperative outcomes and long-term survival analysis. Asian J Endosc Surg 2021. [PMID: 33605064 DOI: 10.1111/ases.12926] [Reference Citation Analysis]
126 Merkow RP, Bentrem DJ. Importance of and adherence to lymph node staging standards in gastrointestinal cancer. Surg Oncol Clin N Am 2012;21:407-16, viii. [PMID: 22583990 DOI: 10.1016/j.soc.2012.03.010] [Reference Citation Analysis]
127 Pacelli F, Rosa F, Marrelli D, Pedrazzani C, Bossola M, Zoccali M, Marchet A, Di Cosmo M, Roata C, Graziosi L, Cavazzoni E, Covino M, D'Ugo D, Roviello F, Nitti D, Doglietto GB. Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann Surg Oncol. 2011;18:1615-1623. [PMID: 21240561 DOI: 10.1245/s10434-010-1543-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
128 Roviello F, Pedrazzani C, Marrelli D, Di Leo A, Caruso S, Giacopuzzi S, Corso G, de Manzoni G. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36:439-446. [PMID: 20392590 DOI: 10.1016/j.ejso.2010.03.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
129 Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Vd Wurff AA, Bosscha K, Coebergh JW. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010;46:1101-1110. [PMID: 20219351 DOI: 10.1016/j.ejca.2010.02.013] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 8.9] [Reference Citation Analysis]
130 Sun X, Liu X, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Chin J Cancer. 2016;35:57. [PMID: 27342313 DOI: 10.1186/s40880-016-0122-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
131 Msika S, Kianmanesh R. Le traitement du cancer gastrique. Chirurgie 1999;124:560-7. [DOI: 10.1016/s0001-4001(00)88281-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
132 Allum WH. Optimal surgery for gastric cancer: is more always better? Recent Results Cancer Res. 2012;196:215-227. [PMID: 23129377 DOI: 10.1007/978-3-642-31629-6_15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
133 Lim DH, Kim HS, Park YS, Lee J, Park SH, Lim HY, Ji SH, Park MJ, Yi SY, An JY, Sohn TS, Noh JH, Bae JM, Kim S, Park CK, Kang WK. Metastatic lymph node in gastric cancer; is it a real distant metastasis? BMC Cancer 2010;10:25. [PMID: 20113485 DOI: 10.1186/1471-2407-10-25] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
134 Kirchoff DD, Deutsch GB, Fujita M, Lee DY, Sim MS, Lee JH, Bilchik AJ. Overall Survival Is Impacted by Birthplace and Not Extent of Surgery in Asian Americans with Resectable Gastric Cancer. J Gastrointest Surg 2015;19:1966-73. [PMID: 26307345 DOI: 10.1007/s11605-015-2919-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
135 Forshaw MJ, Gossage JA, Ockrim J, Atkinson SW, Mason RC. Left thoracoabdominal esophagogastrectomy: still a valid operation for carcinoma of the distal esophagus and esophagogastric junction. Diseases of the Esophagus 2006;19:340-5. [DOI: 10.1111/j.1442-2050.2006.00593.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
136 Kappas AM, Fatouros M, Roukos DH. It Is Still Not the Time to Change Surgical Strategy for Gastric Cancer: In Reply. Ann Surg Oncol 2005;12:194-6. [DOI: 10.1245/aso.2005.11.914] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
137 van de Velde CJ. Current role of surgery and multimodal treatment in localized gastric cancer. Ann Oncol 2008;19 Suppl 5:v93-8. [PMID: 18611909 DOI: 10.1093/annonc/mdn319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
138 Alimoğlu O, Atak İ, Eren T, Kılıç A. Robot assisted laparoscopic (RAL) gastrectomy: case series and a review of the literature. Ulus Cerrahi Derg 2013;29:187-91. [PMID: 25931874 DOI: 10.5152/UCD.2013.2045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
139 Kauppila JH, Lagergren J. The surgical management of esophago-gastric junctional cancer. Surg Oncol. 2016;25:394-400. [PMID: 27916171 DOI: 10.1016/j.suronc.2016.09.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
140 Khushalani NI. Cancer of the Esophagus and Stomach. Mayo Clinic Proceedings 2008;83:712-22. [DOI: 10.1016/s0025-6196(11)60900-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 1] [Article Influence: 3.4] [Reference Citation Analysis]
141 Landheer M, Therasse P, van de Velde C. The importance of quality assurance in surgical oncology. European Journal of Surgical Oncology (EJSO) 2002;28:571-602. [DOI: 10.1053/ejso.2002.1255] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
142 Joharatnam-Hogan N, Shiu KK, Khan K. Challenges in the treatment of gastric cancer in the older patient. Cancer Treat Rev. 2020;85:101980. [PMID: 32065879 DOI: 10.1016/j.ctrv.2020.101980] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
143 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
144 Wang X, Wan F, Pan J, Yu G, Chen Y, Wang J. Prognostic value of the ratio of metastatic lymph nodes in gastric cancer: An analysis based on a Chinese population. J Surg Oncol 2009;99:329-34. [DOI: 10.1002/jso.21247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
145 de Steur WO, Hartgrink HH, Dikken JL, Putter H, van de Velde CJ. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial. Br J Surg 2015;102:1388-93. [PMID: 26313463 DOI: 10.1002/bjs.9891] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
146 Hundahl SA. Surgery for gastric cancer: what the trials indicate. Surg Oncol Clin N Am 2012;21:79-97. [PMID: 22098833 DOI: 10.1016/j.soc.2011.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
147 Peeters KC, Hundahl SA, Kranenbarg EK, Hartgrink H, van de Velde CJ. Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg. 2005;29:1576-1584. [PMID: 16317484 DOI: 10.1007/s00268-005-7907-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
148 Seo KW, Yoon KY. [Individualized surgery for gastric cancer]. Korean J Gastroenterol 2011;57:335-9. [PMID: 21694484 DOI: 10.4166/kjg.2011.57.6.335] [Reference Citation Analysis]
149 Bilici A, Ustaalioglu BB, Seker M, Kefeli U, Canpolat N, Tekinsoy B, Ozugur S, Gumus M. The role of 18F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making? Eur J Nucl Med Mol Imaging. 2011;38:64-73. [PMID: 20838995 DOI: 10.1007/s00259-010-1611-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
150 Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg. 2007;11:158-165. [PMID: 17390167 DOI: 10.1007/s11605-006-0018-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
151 Cuschieri A, Talbot IC, Weeden S; MRC Upper GI Cancer Working Party. Influence of pathological tumour variables on long-term survival in resectable gastric cancer. Br J Cancer 2002;86:674-9. [PMID: 11875724 DOI: 10.1038/sj.bjc.6600161] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
152 Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang D. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg. 2011;396:615-623. [PMID: 21380618 DOI: 10.1007/s00423-011-0753-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
153 Chen HN, Chen XZ, Zhang WH, Chen XL, Yang K, Liu JP, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Necessity of harvesting at least 25 lymph nodes in patients with stage N2-N3 resectable gastric cancer: a 10-year, single-institution cohort study. Medicine (Baltimore) 2015;94:e620. [PMID: 25761190 DOI: 10.1097/MD.0000000000000620] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
154 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 408] [Article Influence: 52.9] [Reference Citation Analysis]
155 Roukos DH. Adjuvant chemoradiotherapy in gastric cancer: Wave goodbye to extensive surgery? Annals of Surgical Oncology 2002;9:220-1. [DOI: 10.1007/bf02573057] [Cited by in Crossref: 64] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
156 Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245:426-434. [PMID: 17435550 DOI: 10.1097/01.sla.0000245469.35088.42] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
157 Thiels CA, Hanson KT, Habermann EB, Boughey JC, Grotz TE. Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer. Cancer 2019;126:1283-94. [DOI: 10.1002/cncr.32660] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
158 Brenkman HJ, Haverkamp L, Ruurda JP, van Hillegersberg R. Worldwide practice in gastric cancer surgery. World J Gastroenterol 2016; 22(15): 4041-4048 [PMID: 27099448 DOI: 10.3748/wjg.v22.i15.4041] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
159 Brind'Amour A, Gagné JP, Hogue JC, Poirier É. Impact of the introduction of formal D2 lymphadenectomy for gastric cancer in a Western setting. Can J Surg 2021;64:E119-26. [PMID: 33651574 DOI: 10.1503/cjs.019919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Nussbaum DP, Pappas TN, Perez A. Laparoscopic Total Gastrectomy in the Western Patient Population: Tips, Techniques, and Evidence-based Practice. Surg Laparosc Endosc Percutan Tech 2015;25:455-61. [PMID: 26492457 DOI: 10.1097/SLE.0000000000000210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
161 Al-Moundhri MS, Al-Bahrani B, Burney IA, Nirmala V, Al-Madhani A, Al-Mawaly K, Al-Nabhani M, Thomas V, Ganguly SS, Grant CS. The prognostic determinants of gastric cancer treatment outcome in Omani Arab patients. Oncology. 2006;70:90-96. [PMID: 16601367 DOI: 10.1159/000092584] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
162 Hoshi H. Standard D2 and Modified Nodal Dissection for Gastric Adenocarcinoma. Surgical Oncology Clinics of North America 2012;21:57-70. [DOI: 10.1016/j.soc.2011.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
163 Sun W, Haller DG. Recent Advances in the Treatment of Gastric Cancer: . Drugs 2001;61:1545-51. [DOI: 10.2165/00003495-200161110-00002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
164 Mckay A, Sutherland FR, Bathe OF, Dixon E. Morbidity and Mortality Following Multivisceral Resections in Complex Hepatic and Pancreatic Surgery. J Gastrointest Surg 2008;12:86-90. [DOI: 10.1007/s11605-007-0273-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
165 Sung JJY, Ng EKW, Lin J, Ho KY, Ji J, Sugano K, Poon RTP, Chan ATC, Goh K, Han K, Chen LLT, Wu K, Ng SSM, Bresalier RS, Chan FKL; the Asia Pacific GI Oncology Summit Group. Digestive cancer management in Asia: Position statements: A report on GI Oncology Summit in 2011: Digestive cancer management in Asia. Journal of Gastroenterology and Hepatology 2012;27:1417-22. [DOI: 10.1111/j.1440-1746.2012.07194.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
166 Yaprak G, Tataroglu D, Dogan B, Pekyurek M. Prognostic factors for survival in patients with gastric cancer: Single-centre experience. North Clin Istanb 2020;7:146-52. [PMID: 32259036 DOI: 10.14744/nci.2019.73549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Ergul E, Gozetlik EO. Emergency spontaneous gastric perforations: ulcus versus cancer. Langenbecks Arch Surg 2009;394:643-6. [DOI: 10.1007/s00423-008-0331-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
168 Aiolfi A, Asti E, Siboni S, Bernardi D, Rausa E, Bonitta G, Bonavina L. Impact of spleen-preserving total gastrectomy on postoperative infectious complications and 5-year overall survival: systematic review and meta-analysis of contemporary randomized clinical trials. Curr Oncol 2019;26:e202-9. [PMID: 31043828 DOI: 10.3747/co.26.4391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
169 Eom BW, Joo J, Kim Y, Park B, Park JY, Yoon HM, Lee JH, Ryu KW. Is There Any Role of Additional Retropancreatic Lymph Node Dissection on D2 Gastrectomy for Advanced Gastric Cancer? Ann Surg Oncol 2013;20:2669-75. [DOI: 10.1245/s10434-013-2938-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
170 Mao ZY, Guo XC, Su D, Wang LJ, Zhang TT, Bai L. Retrospective evaluation of the efficacy of first-line treatment of advanced gastric cancer with docetaxel and oxaliplatin. Cancer Invest 2015;33:16-21. [PMID: 25495414 DOI: 10.3109/07357907.2014.988342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
171 Cho H, Yoshikawa T, Oba MS, Hirabayashi N, Shirai J, Aoyama T, Hayashi T, Yamada T, Oba K, Morita S, Sakamoto J, Tsuburaya A. Matched Pair Analysis to Examine the Effects of a Planned Preoperative Exercise Program in Early Gastric Cancer Patients with Metabolic Syndrome to Reduce Operative Risk: The Adjuvant Exercise for General Elective Surgery (AEGES) Study Group. Ann Surg Oncol 2014;21:2044-50. [DOI: 10.1245/s10434-013-3394-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
172 Kim IH, Park SS, Lee CM, Kim MC, Kwon IK, Min JS, Kim HI, Lee HH, Lee SI, Chae H. Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study. Ann Surg Oncol. 2018;25:1176-1183. [PMID: 29450755 DOI: 10.1245/s10434-018-6375-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
173 Tóth D, Kathy S, Csobán T, Kincses Z, Török M, Plósz J, Damjanovich L. [Prospective comparative study of sentinel lymph node mapping in gastric cancer -- submucosal versus subserosal marking method]. Magy Seb. 2012;65:3-8. [PMID: 22343099 DOI: 10.1556/maseb.65.2012.1.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
174 Nussbaum DP, Rushing CN, Sun Z, Yerokun BA, Worni M, Saunders RS, McClellan MB, Niedzwiecki D, Greenup RA, Blazer DG 3rd. Hospital-level compliance with the commission on cancer's quality of care measures and the association with patient survival. Cancer Med 2021;10:3533-44. [PMID: 33943026 DOI: 10.1002/cam4.3875] [Reference Citation Analysis]
175 Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, Otsuji E. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer. 2011;14:172-177. [PMID: 21331530 DOI: 10.1007/s10120-011-0028-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
176 Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg. 2013;17:2059-2066. [PMID: 24129828 DOI: 10.1007/s11605-013-2380-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
177 Günther K, Horbach T, Merkel S, Meyer M, Schnell U, Klein P, Hohenberger W. D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications. Surg Today 2000;30:700-5. [PMID: 10955732 DOI: 10.1007/s005950070080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
178 Marano L, Polom K, Patriti A, Roviello G, Falco G, Stracqualursi A, De Luca R, Petrioli R, Martinotti M, Generali D, Marrelli D, Di Martino N, Roviello F. Surgical management of advanced gastric cancer: An evolving issue. Eur J Surg Oncol. 2016;42:18-27. [PMID: 26632080 DOI: 10.1016/j.ejso.2015.10.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
179 Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer. 2010;13:137-148. [PMID: 20820982 DOI: 10.1007/s10120-010-0560-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
180 Suh Y, Yang H. Screening and Early Detection of Gastric Cancer. Surgical Clinics of North America 2015;95:1053-66. [DOI: 10.1016/j.suc.2015.05.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
181 Stumpf PK, Amini A, Jones BL, Koshy M, Sher DJ, Lieu CH, Schefter TE, Goodman KA, Rusthoven CG. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis. Cancer. 2017;123:3402-3409. [PMID: 28513823 DOI: 10.1002/cncr.30748] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
182 Tsirlis TD, Papastratis G, Masselou K, Tsigris C, Papachristodoulou A, Kostakis A, Nikiteas NI. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 2008; 14(17): 2691-2701 [PMID: 18461654 DOI: 10.3748/wjg.14.2691] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
183 Helyer LK, O'Brien C, Coburn NG, Swallow CJ. Surgeons' knowledge of quality indicators for gastric cancer surgery. Gastric Cancer 2007;10:205-14. [PMID: 18095075 DOI: 10.1007/s10120-007-0435-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
184 Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U, Wilkinson NW. Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol. 2014;21:3008-3014. [PMID: 24700300 DOI: 10.1245/s10434-014-3664-z] [Cited by in Crossref: 121] [Cited by in F6Publishing: 114] [Article Influence: 17.3] [Reference Citation Analysis]
185 Degiuli M, Sasako M, Ponti A; Italian Gastric Cancer Study Group. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010;97:643-649. [PMID: 20186890 DOI: 10.1002/bjs.6936] [Cited by in Crossref: 187] [Cited by in F6Publishing: 176] [Article Influence: 17.0] [Reference Citation Analysis]
186 Chen QY, Lin GT, Zhong Q, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Huang CM. Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance. Gastric Cancer 2020;23:184-94. [PMID: 31300914 DOI: 10.1007/s10120-019-00986-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
187 Collard M, Marchese T, Guedj N, Cauchy F, Chassaing C, Ronot M, Dokmak S, Soubrane O, Sauvanet A. Is Routine Splenectomy Justified for All Left-Sided Pancreatic Cancers? Ann Surg Oncol. 2019;26:1071-1078. [PMID: 30607766 DOI: 10.1245/s10434-018-07123-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
188 Bozzetti F. Principles of Surgical Radicality in the Treatment of Gastric Cancer. Surgical Oncology Clinics of North America 2001;10:833-54. [DOI: 10.1016/s1055-3207(18)30035-8] [Cited by in Crossref: 15] [Article Influence: 0.8] [Reference Citation Analysis]
189 Khedmat H, Panahian M, Mashahdian M, Rajabpour MV, Zendehdel K. Prognostic factors and survival in stomach cancer - analysis of 15 years of data from a referral hospital in iran and evaluation of international variation. Onkologie 2011;34:178-82. [PMID: 21447975 DOI: 10.1159/000327007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Zulfikaroglu B, Koc M, Ozmen MM, Kucuk NO, Ozalp N, Aras G. Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery. 2005;138:899-904. [PMID: 16291391 DOI: 10.1016/j.surg.2005.04.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
191 Tokunaga M, Hiki N, Fukunaga T, Ohyama S, Yamada K, Yamaguchi T. Better prognosis of T2 gastric cancer with preoperative diagnosis of early gastric cancer. Ann Surg Oncol 2009;16:1514-9. [PMID: 19290492 DOI: 10.1245/s10434-009-0404-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
192 House MG, Brennan MF. Neoadjuvant therapy for gastric cancer. Adv Surg. 2008;42:151-168. [PMID: 18953815 DOI: 10.1016/j.yasu.2008.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
193 Chen S, Li YF, Feng XY, Zhou ZW, Yuan XH, Chen YB. Significance of palliative gastrectomy for late-stage gastric cancer patients. J Surg Oncol. 2012;106:862-871. [PMID: 22648960 DOI: 10.1002/jso.23158] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
194 Dai M, Shi N, Xing C, Liao Q, Zhang T, Chen G, Wu W, Guo J, Liu Z, Zhao Y. Splenic preservation in laparoscopic distal pancreatectomy. British Journal of Surgery 2017;104:452-62. [DOI: 10.1002/bjs.10434] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
195 Hoshi H. Management of Gastric Adenocarcinoma for General Surgeons. Surg Clin North Am 2020;100:523-34. [PMID: 32402298 DOI: 10.1016/j.suc.2020.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
196 Roukos DH. Extended (D2) Lymph Node Dissection for Gastric Cancer: Do Patients Benefit? Ann Surg Oncol 2000;7:253-5. [DOI: 10.1007/s10434-000-0253-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 3.2] [Reference Citation Analysis]
197 Tóth D, Plósz J, Török M. Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol 2016; 8(2): 136-146 [PMID: 26909128 DOI: 10.4251/wjgo.v8.i2.136] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
198 Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol. 2003;46:59-100. [PMID: 12672518 DOI: 10.1016/S1040-8428(02)00160-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
199 Macdonald JS, Hundahl S, Smalley SR, O’dea D, Mitchell EP. Gastric Cancer. In: Blanke CD, Rödel C, Talamonti MS, editors. Gastrointestinal Oncology. Berlin: Springer Berlin Heidelberg; 2011. pp. 101-38. [DOI: 10.1007/978-3-642-13306-0_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
200 Chen FF, Huang DD, Lu JX, Zhou CJ, Zhuang CL, Wang SL, Shen X, Yu Z, Chen XL. Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes. J Gastrointest Surg 2016;20:521-30. [PMID: 26691150 DOI: 10.1007/s11605-015-3059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
201 Leissner J. [Lymphadenectomy for bladder cancer. Diagnostic and prognostic significance as well as therapeutic benefit]. Urologe A 2005;44:638-44. [PMID: 15871006 DOI: 10.1007/s00120-005-0827-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
202 Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer 2001;84:1602-9. [PMID: 11401312 DOI: 10.1054/bjoc.2001.1720] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
203 Morkavuk ŞB, Çulcu S, Tez M, Ünal AE. The efficiency of D1(+) lymphadenectomy in signet ring cell carcinoma: comparison of postoperative early and late outcomes between standard lymphadenectomy and D1(+) lymphadenectomy. Libyan J Med 2021;16:1973761. [PMID: 34482797 DOI: 10.1080/19932820.2021.1973761] [Reference Citation Analysis]
204 Rausei S, Galli F, Lianos G, Rosa F, Cossu A, Biondi A, Martignoni F, Cananzi FCM, Fumagalli U, Alfieri S, Persiani R, Quagliuolo V, D'Ugo D, Rosati R. How Should We Measure the Quality of Lymphadenectomy for Gastric Cancer? Anatomical Versus Numerical Criterion. J Gastrointest Cancer 2020;51:887-92. [PMID: 31691087 DOI: 10.1007/s12029-019-00321-x] [Reference Citation Analysis]
205 An JY, Cheong JH, Hyung WJ, Noh SH. Recent evolution of surgical treatment for gastric cancer in Korea. J Gastric Cancer. 2011;11:1-6. [PMID: 22076195 DOI: 10.5230/jgc.2011.11.1.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
206 Bozzetti F, Andreola S, Bignami P, Sirizzotti G. Prognostic Effects of Lymph Node Micrometastases in Patients Undergoing Curative Gastrectomy for Cancer. Tumori 2000;86:470-1. [DOI: 10.1177/030089160008600607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
207 Chang JS, Koom WS, Lee Y, Yoon HI, Lee HS. Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection? World J Gastroenterol 2014; 20(36): 12900-12907 [PMID: 25278687 DOI: 10.3748/wjg.v20.i36.12900] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
208 Lo S, Wu C, Shen K, Hsieh M, Lui W. Higher morbidity and mortality after combined total gastrectomy and pancreaticosplenectomy for gastric cancer. World J Surg 2002;26:678-82. [DOI: 10.1007/s00268-001-0289-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
209 Stewart C, Chao J, Chen YJ, Lin J, Sullivan MJ, Melstrom L, Hyung WJ, Fong Y, Paz IB, Woo Y. Multimodality management of locally advanced gastric cancer-the timing and extent of surgery. Transl Gastroenterol Hepatol 2019;4:42. [PMID: 31231709 DOI: 10.21037/tgh.2019.05.02] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
210 Skoropad VY, Berdov BA, Zagrebin VM. Preoperative radiotherapy in combination with metronidazole for resectable gastric cancer: long-term results of a phase 2 study. Eur J Surg Oncol. 2003;29:166-170. [PMID: 12633560 DOI: 10.1053/ejso.2002.1324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
211 Gholami S, Janson L, Worhunsky DJ, Tran TB, Squires MH 3rd, Jin LX, Spolverato G, Votanopoulos KI, Schmidt C, Weber SM, Bloomston M, Cho CS, Levine EA, Fields RC, Pawlik TM, Maithel SK, Efron B, Norton JA, Poultsides GA. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. J Am Coll Surg. 2015;221:291-299. [PMID: 26206635 DOI: 10.1016/j.jamcollsurg.2015.04.024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
212 Kappas AM, Fatouros M, Roukos DH. Is it Time to Change Surgical Strategy for Gastric Cancer in the United States? Ann Surg Oncol 2004;11:727-30. [DOI: 10.1245/aso.2004.05.907] [Cited by in Crossref: 69] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
213 Passot G, Vaudoyer D, Messager M, Brudvik KW, Kim BJ, Mariette C, Glehen O. Is Extended Lymphadenectomy Needed for Elderly Patients With Gastric Adenocarcinoma? Ann Surg Oncol 2016;23:2391-7. [PMID: 27169773 DOI: 10.1245/s10434-016-5260-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
214 Oehler C, Ciernik IF. Radiation therapy and combined modality treatment of gastrointestinal carcinomas. Cancer Treatment Reviews 2006;32:119-38. [DOI: 10.1016/j.ctrv.2006.01.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
215 Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Inoue H, Yamada K, Sano T, Yamaguchi T, Nakajima T. Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial? Ann Surg Oncol. 2009;16:1241-1246. [PMID: 19224285 DOI: 10.1245/s10434-009-0345-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
216 Hundahl SA. Eliminating and suppressing local-regional disease in gastric cancer. J Surg Oncol 2005;90:171-3. [DOI: 10.1002/jso.20224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
217 Lawson JD, Sicklick JK, Fanta PT. Gastric cancer. Curr Probl Cancer. 2011;35:97-127. [PMID: 21635986 DOI: 10.1016/j.currproblcancer.2011.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
218 Gupta V, Raju K, Rao TS, Naidu CK, Goel V, Hariharan N, Nagarajuch R, Madhunarayana B. A Randomized Trial Comparing the Efficacy of Methylene Blue Dye Alone Versus Combination of Methylene Blue Dye and Radioactive Sulfur Colloid in Sentinel Lymph Node Biopsy for Early Stage Breast Cancer Patients. Indian J Surg Oncol 2020;11:216-22. [PMID: 32523266 DOI: 10.1007/s13193-019-01023-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, Rosemeyer D, Johnson CD, Alderson D;  EORTC Quality of Life Group. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37:966-971. [PMID: 11334720 DOI: 10.1016/s0959-8049(00)00417-2] [Cited by in Crossref: 106] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
220 Schwarz RE, Kelsen DP. Postoperative Adjuvant Chemoradiation Therapy for Patients With Resected Gastric Cancer: Intergroup 116. JCO 2001;19:1879-80. [DOI: 10.1200/jco.2001.19.6.1879] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
221 Catarci M, Montemurro LA, Di Cintio A, Ghinassi S, Coppola L, Pinnarelli L, Belardi A, Koch M, Grassi GB. Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution. Updates Surg. 2010;62:89-99. [PMID: 20845010 DOI: 10.1007/s13304-010-0017-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
222 Sasako M. Gastric cancer eastern experience. Surg Oncol Clin N Am. 2012;21:71-77. [PMID: 22098832 DOI: 10.1016/j.soc.2011.09.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
223 Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol. 2001;40:77-94. [PMID: 11578917 DOI: 10.1016/s1040-8428(00)00131-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
224 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
225 Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 2013;5:48-63. [PMID: 24216698 DOI: 10.3390/cancers5010048] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 12.8] [Reference Citation Analysis]
226 Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D;  ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v38-v49. [PMID: 27664260 DOI: 10.1093/annonc/mdw350] [Cited by in Crossref: 609] [Cited by in F6Publishing: 567] [Article Influence: 121.8] [Reference Citation Analysis]
227 Strong VE, Yoon SS. Extended lymphadenectomy in gastric cancer is debatable. World J Surg. 2013;37:1773-1777. [PMID: 23649527 DOI: 10.1007/s00268-013-2070-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
228 Komatsu S, Ichikawa D, Nishimura M, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer. Eur J Surg Oncol 2017;43:203-9. [PMID: 27595506 DOI: 10.1016/j.ejso.2016.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
229 Sharma A, Radhakrishnan V. Gastric cancer in India. Indian J Med Paediatr Oncol 2021;32:12-6. [DOI: 10.4103/0971-5851.81884] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
230 Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim K, Sohn I, Jung SH, Choi MG, Lee JH, Bae JM, Kim S, Kim ST, Park JO, Park YS, Lim HY, Kang WK. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. JCO 2015;33:3130-6. [DOI: 10.1200/jco.2014.58.3930] [Cited by in Crossref: 209] [Cited by in F6Publishing: 126] [Article Influence: 34.8] [Reference Citation Analysis]
231 Yasuda K, Shiraishi N, Adachi Y, Inomata M, Sato K, Kitano S. Risk factors for complications following resection of large gastric cancer. Br J Surg 2001;88:873-7. [PMID: 11412261 DOI: 10.1046/j.0007-1323.2001.01782.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
232 Wagner AD, Schneider PM, Fleig WE. The role of chemotherapy in patients with established gastric cancer. Best Pract Res Clin Gastroenterol 2006;20:789-99. [PMID: 16997160 DOI: 10.1016/j.bpg.2006.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
233 Meimarakis G, Winter H, Assmann I, Kopp R, Lehn N, Kist M, Stolte M, Jauch KW, Hatz RA. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol. 2006;7:211-222. [PMID: 16510330 DOI: 10.1016/s1470-2045(06)70586-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
234 Meyer HJ, Hölscher AH, Lordick F, Messmann H, Mönig S, Schumacher C, Stahl M, Wilke H, Möhler M. [Current S3 guidelines on surgical treatment of gastric carcinoma]. Chirurg 2012;83:31-7. [PMID: 22127381 DOI: 10.1007/s00104-011-2149-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
235 Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J, Abrams RA, Laheru D, Hruban RH, Yeo CJ. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg. 2005;9:1191-1204; discussion 1204-1206. [PMID: 16332474 DOI: 10.1016/j.gassur.2005.08.034] [Cited by in Crossref: 164] [Cited by in F6Publishing: 136] [Article Influence: 10.9] [Reference Citation Analysis]
236 Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J. Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer. 2000;36:390-396. [PMID: 10708942 DOI: 10.1016/s0959-8049(99)00308-1] [Cited by in Crossref: 78] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
237 Song X, Wang L, Chen W, Pan T, Zhu H, Xu J, Jin M, Finley RK, Wu J. Lymphatic mapping and sentinel node biopsy in gastric cancer. Am J Surg. 2004;187:270-273. [PMID: 14769318 DOI: 10.1016/j.amjsurg.2003.11.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
238 Hazard L, O’Connor J, Scaife C. Role of radiation therapy in gastric adenocarcinoma. World J Gastroenterol 2006; 12(10): 1511-1520 [PMID: 16570342 DOI: 10.3748/wjg.v12.i10.1511] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
239 Ichikura T, Chochi K, Sugasawa H, Yaguchi Y, Sakamoto N, Takahata R, Kosuda S, Mochizuki H. Individualized surgery for early gastric cancer guided by sentinel node biopsy. Surgery. 2006;139:501-507. [PMID: 16627059 DOI: 10.1016/j.surg.2005.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
240 McLoughlin JM. Adenocarcinoma of the stomach: a review. Proc (Bayl Univ Med Cent) 2004;17:391-9. [PMID: 16200126 DOI: 10.1080/08998280.2004.11928001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
241 Lim L, Michael M, Mann GB, Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol. 2005;23:6220-6232. [PMID: 16135489 DOI: 10.1200/jco.2005.11.593] [Cited by in Crossref: 112] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
242 Munson JL, O'Mahony R. Radical gastrectomy for cancer of the stomach. Surg Clin North Am. 2005;85:1021-1032, vii. [PMID: 16139034 DOI: 10.1016/j.suc.2005.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
243 Yakoub D, Athanasiou T, Tekkis P, Hanna GB. Laparoscopic assisted distal gastrectomy for early gastric cancer: is it an alternative to the open approach? Surg Oncol 2009;18:322-33. [PMID: 18922689 DOI: 10.1016/j.suronc.2008.08.006] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
244 Schimanski CC, Schlaegel F, Jordan M, Moehler M, Sgourakis G, Drescher DG, Galle PR, Lang H, Gockel I. VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery. World J Surg 2011;35:1010-6. [PMID: 21387130 DOI: 10.1007/s00268-011-1041-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
245 Peeters K, van de Velde C. Quality assurance of surgery in gastric and rectal cancer. Critical Reviews in Oncology/Hematology 2004;51:105-19. [DOI: 10.1016/j.critrevonc.2004.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
246 Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol. 2005;12:981-987. [PMID: 16244801 DOI: 10.1245/ASO.2005.03.008] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
247 Orman S, Cayci HM. Gastric cancer: factors affecting survival. Acta Chir Belg 2019;119:24-30. [PMID: 29560799 DOI: 10.1080/00015458.2018.1453437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
248 Yamamoto N, Oshima T, Sato T, Makino H, Nagano Y, Fujii S, Rino Y, Imada T, Kunisaki C. Upper abdominal body shape is the risk factor for postoperative pancreatic fistula after splenectomy for advanced gastric cancer: a retrospective study. World J Surg Oncol. 2008;6:109. [PMID: 18847461 DOI: 10.1186/1477-7819-6-109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
249 Jiang N, Deng JY, Ding XW, Zhang L, Liu HG, Liang YX, Liang H. Effect of complication grade on survival following curative gastrectomy for carcinoma. World J Gastroenterol 2014; 20(25): 8244-8252 [PMID: 25009399 DOI: 10.3748/wjg.v20.i25.8244] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
250 Tokunaga M, Hiki N, Fukunaga T, Ogura T, Miyata S, Yamaguchi T. Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br J Surg. 2009;96:496-500. [PMID: 19358176 DOI: 10.1002/bjs.6586] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
251 Ozmen MM, Ozmen F, Zulfikaroglu B. Lymph nodes in gastric cancer. J Surg Oncol 2008;98:476-81. [DOI: 10.1002/jso.21134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
252 Mezhir JJ, Pillarisetty VG, Shah MA, Coit DG. Randomized clinical trials in gastric cancer. Surg Oncol Clin N Am 2010;19:81-100. [PMID: 19914561 DOI: 10.1016/j.soc.2009.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
253 Jiang L, Yang K, Chen Y, Guan Q, Zhao P, Tian J, Wang Q. Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer. British Journal of Surgery 2014;101:595-604. [DOI: 10.1002/bjs.9497] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
254 Yarema R, de Manzoni G, Fetsych T, Ohorchak M, Pliatsko M, Bencivenga M. On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer. World J Gastrointest Oncol 2016; 8(6): 489-497 [PMID: 27326318 DOI: 10.4251/wjgo.v8.i6.489] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
255 Solsky I, In H. Surgical Treatment for Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:581-605. [PMID: 34053640 DOI: 10.1016/j.giec.2021.04.001] [Reference Citation Analysis]
256 Van Cutsem E, Van de Velde C, Roth A, Lordick F, Köhne CH, Cascinu S, Aapro M. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group. Eur J Cancer. 2008;44:182-194. [PMID: 18093827 DOI: 10.1016/j.ejca.2007.11.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
257 Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T. An adequate perioperative management and strategy for gastric cancer after coronary artery bypass using the right gastroepiploic artery. Surg Today. 2013;43:284-288. [PMID: 22706786 DOI: 10.1007/s00595-012-0224-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
258 He J, McGee DL, Niu X. Application of the Bayesian dynamic survival model in medicine. Stat Med 2010;29:347-60. [PMID: 20014356 DOI: 10.1002/sim.3795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
259 Memon MA, Butler N, Memon B. The issue of lymphadenectomy during laparoscopic gastrectomy for gastric carcinoma. World J Gastrointest Oncol 2010; 2(2): 65-67 [PMID: 21160923 DOI: 10.4251/wjgo.v2.i2.65] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
260 Propper D, Jones K, Anthoney DA, Mansoor W, Ford D, Eatock M, Agarwal R, Inatani M, Saito T, Abe M, Evans TR. Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma. BMC Cancer 2016;16:779. [PMID: 27724887 DOI: 10.1186/s12885-016-2828-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
261 de Manzoni G, Di Leo A, Pedrazzani C, Castaldini G, Borzellino G, Veraldi G, Cordiano C. Intraoperative US staging of T in gastric cancer: Final results of a blind prospective study. J Surg Oncol 2001;78:158-61. [DOI: 10.1002/jso.1141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
262 Zia MK, Morris-Stiff G, Luhmann A, Jeffries R, Ehsan O, Hassn A. Safety and application of laparoscopic gastrectomy for benign gastric disease and gastric cancer. Ann R Coll Surg Engl 2011;93:17-21. [PMID: 20810021 DOI: 10.1308/003588410X12771863936963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
263 Kim MS, Yoo SY, Cho CK, Yoo HJ, Yang KM, Kang JK, Lee DH, Lee JI, Bang HY, Kim MS, Kang HJ. Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer. J Korean Med Sci 2009;24:488-92. [PMID: 19543514 DOI: 10.3346/jkms.2009.24.3.488] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
264 Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn N. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60-S69. [PMID: 22138927 DOI: 10.1007/s10120-011-0110-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
265 Young JA, Shimi SM, Kerr L, McPhillips G, Thompson AM. Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis. Ann Med Surg (Lond). 2014;3:26-30. [PMID: 25568781 DOI: 10.1016/j.amsu.2014.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
266 Kodera Y, Schwarz RE, Nakao A. Extended lymph node dissection in gastric carcinoma. Journal of the American College of Surgeons 2002;195:855-64. [DOI: 10.1016/s1072-7515(02)01496-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
267 Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol 2002;9:828-30. [PMID: 12417502 DOI: 10.1007/BF02557517] [Cited by in Crossref: 66] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
268 Wang Q, Dang T, Meng X, Li K, Ren W, Ma X, Huang Y, Wu X, Han W, Zhang D, Li X, Wang D, Zheng L. Is concomitant splenectomy necessary in radical gastric cancer surgery? A systematic review and meta-analysis. Asia Pac J Clin Oncol 2019;15:e28-35. [PMID: 30178572 DOI: 10.1111/ajco.13052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
269 Marrelli D, Pedrazzani C, Neri A, Corso G, DeStefano A, Pinto E, Roviello F. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol. 2007;14:25-33. [PMID: 17024558 DOI: 10.1245/s10434-006-9063-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
270 Chandran S, Vaughan R, Jacob A, Hamilton C, Joon DL, Lim K, Tog C, Bhatia K, Aly A, Sweeney T, Efthymiou M. A novel endoscopic marker for radiological localization and image-guided radiotherapy in esophageal and gastric cancers (with video). Gastrointest Endosc 2016;83:309-17. [PMID: 26239307 DOI: 10.1016/j.gie.2015.06.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
271 McCulloch P, Niita ME, Kazi H, Gama-Rodrigues JJ. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 2005;92:5-13. [PMID: 15635680 DOI: 10.1002/bjs.4839] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
272 McCall MD, Graham PJ, Bathe OF. Quality of life: A critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol 2016; 22(3): 1101-1113 [PMID: 26811650 DOI: 10.3748/wjg.v22.i3.1101] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
273 Nitti D, Wils J, Dos Santos JG, Fountzilas G, Conte PF, Sava C, Tres A, Coombes RC, Crivellari D, Marchet A. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann Oncol. 2006;17:262-269. [PMID: 16293676 DOI: 10.1093/annonc/mdj077] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
274 Weitz J, D’angelica M, Gonen M, Klimstra D, Coit DG, Brennan MF, Karpeh MS. Interaction of Splenectomy and Perioperative Blood Transfusions on Prognosis of Patients With Proximal Gastric and Gastroesophageal Junction Cancer. JCO 2003;21:4597-603. [DOI: 10.1200/jco.2003.12.136] [Cited by in Crossref: 36] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
275 Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Wang JB. Impact of the number of dissected lymph nodes on survival for gastric cancer after distal subtotal gastrectomy. Gastroenterol Res Pract 2011;2011:476014. [PMID: 21811495 DOI: 10.1155/2011/476014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
276 Schumacher G, Schmidt SC, Schlechtweg N, Roesch T, Sacchi M, von Dossow V, Chopra SS, Pratschke J, Zhukova J, Stieler J. Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction. Dis Esophagus. 2009;22:422-426. [PMID: 19191862 DOI: 10.1111/j.1442-2050.2008.00923.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
277 Mocellin S, McCulloch P, Kazi H, Gama-Rodrigues JJ, Yuan Y, Nitti D. Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2015;:CD001964. [PMID: 26267122 DOI: 10.1002/14651858.CD001964.pub4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
278 Imamura H, Kurokawa Y, Kawada J, Tsujinaka T, Takiguchi S, Fujiwara Y, Mori M, Doki Y. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg. 2011;35:625-630. [PMID: 21161652 DOI: 10.1007/s00268-010-0914-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
279 Zhang CD, Yamashita H, Seto Y. Gastric cancer surgery: historical background and perspective in Western countries versus Japan. Ann Trans Med. 2019;7(18):493. [PMID: 31700929 DOI: 10.21037/atm.2019.08.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
280 Gill S, Shah A, Le N, Cook EF, Yoshida EM. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. J Clin Oncol. 2003;21:2070-2076. [PMID: 12775731 DOI: 10.1200/jco.2003.11.054] [Cited by in Crossref: 93] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
281 Fuse N, Bando H, Chin K, Ito S, Yoshikawa T, Tsuburaya A, Terashima M, Kawashima Y, Fukunaga T, Gotoh M, Emi Y, Yoshida K, Oki E, Takahashi S, Kuriki H, Sato K, Sasako M. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Gastric Cancer. 2017;20:332-340. [PMID: 26956689 DOI: 10.1007/s10120-016-0606-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
282 Garg PK, Jakhetiya A, Sharma J, Ray MD, Pandey D. Lymphadenectomy in gastric cancer: Contentious issues. World J Gastrointest Surg 2016; 8(4): 294-300 [PMID: 27152135 DOI: 10.4240/wjgs.v8.i4.294] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
283 Costa ML, de Cássia Braga Ribeiro K, Machado MA, Costa AC, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Ann Surg Oncol 2006;13:843-50. [PMID: 16614885 DOI: 10.1245/ASO.2006.05.040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
284 Tóth D, Török M, Kincses Z, Damjanovich L. Prospective, comparative study for the evaluation of lymph node involvement in gastric cancer: Maruyama computer program versus sentinel lymph node biopsy. Gastric Cancer. 2013;16:201-207. [PMID: 22740059 DOI: 10.1007/s10120-012-0170-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
285 Lam S, Tan E, Menezes A, Martin D, Gallagher J, Storey D, Sandroussi C. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching. World J Surg Oncol 2018;16:136. [PMID: 29986713 DOI: 10.1186/s12957-018-1422-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
286 Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol. 2007;46:277-285. [PMID: 17450463 DOI: 10.1080/02841860701218634] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
287 Dudeja V, Habermann EB, Abraham A, Zhong W, Parsons HM, Tseng JF, Al-Refaie WB. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma? J Gastrointest Surg. 2012;16:238-246; discussion 246-247. [PMID: 22089951 DOI: 10.1007/s11605-011-1756-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
288 Kung CH, Song H, Ye W, Nilsson M, Johansson J, Rouvelas I, Irino T, Lundell L, Tsai JA, Lindblad M. Extent of lymphadenectomy has no impact on postoperative complications after gastric cancer surgery in Sweden. Chin J Cancer Res 2017;29:313-22. [PMID: 28947863 DOI: 10.21147/j.issn.1000-9604.2017.04.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
289 Park SS, Park JM, Kim JH, Kim WB, Lee J, Kim SJ, Kim CS, Mok YJ. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit? J Surg Oncol 2006;94:16-20. [PMID: 16788938 DOI: 10.1002/jso.20560] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
290 Surenkok S, Beyzadeoglu M, Oysul K, Ozyigit G, Ataergin S, Arpaci F, Ozet A. The Management of Gastric Adenocarcinoma with Postoperative Chemoirradiation. A non-randomized comparison of oral UFT and 5-FU. Tumori 2008;94:70-4. [DOI: 10.1177/030089160809400113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
291 Skoropad V, Berdov B, Zagrebin V. Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial. J Surg Oncol. 2002;80:72-78. [PMID: 12173383 DOI: 10.1002/jso.10102] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
292 Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2005;2:98-107. [PMID: 16264882 DOI: 10.1038/ncponc0099] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 7.4] [Reference Citation Analysis]
293 Kodera Y, Fujiwara M, Koike M, Nakao A. Chemotherapy as a component of multimodal therapy for gastric carcinoma. World J Gastroenterol 2006; 12(13): 2000-2005 [PMID: 16610047 DOI: 10.3748/wjg.v12.i13.2000] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
294 de Gara CJ, Hanson J, Hamilton S. A population-based study of tumor-node relationship, resection margins, and surgeon volume on gastric cancer survival. Am J Surg. 2003;186:23-27. [PMID: 12842743 DOI: 10.1016/s0002-9610(03)00116-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
295 Choi YY, Noh SH, Cheong JH. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J 2015;56:1177-85. [PMID: 26256958 DOI: 10.3349/ymj.2015.56.5.1177] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
296 Grossmann EM, Longo WE, Virgo KS, Johnson FE, Oprian CA, Henderson W, Daley J, Khuri SF. Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery. 2002;131:484-490. [PMID: 12019399 DOI: 10.1067/msy.2002.123806] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
297 Graziosi L, Marino E, Cavazzoni E, Donini A. Prognostic value of the seventh AJCC/UICC TNM classification of non-cardia gastric cancer. World J Surg Oncol 2013;11:103. [PMID: 23687939 DOI: 10.1186/1477-7819-11-103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
298 Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, Yang HK. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg. 2012;255:50-58. [PMID: 21577089 DOI: 10.1097/sla.0b013e31821d4d75] [Cited by in Crossref: 94] [Cited by in F6Publishing: 45] [Article Influence: 10.4] [Reference Citation Analysis]
299 Ashraf N, Hoffe S, Kim R. Adjuvant treatment for gastric cancer: chemotherapy versus radiation. Oncologist 2013;18:1013-21. [PMID: 23966224 DOI: 10.1634/theoncologist.2012-0462] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
300 Van Cutsem E, Dicato M, Arber N, Benson A, Cunningham D, Diaz-Rubio E, Glimelius B, Goldberg R, Haller D, Haustermans K, Koo-Kang Y, Labianca R, Lang I, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Szawlowski A, van de Velde C. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. Ann Oncol 2006;17 Suppl 6:vi13-8. [PMID: 16809641 DOI: 10.1093/annonc/mdl976] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
301 Heemskerk VH, Lentze F, Hulsewé KW, Hoofwijk TG. Gastric carcinoma: review of the results of treatment in a community teaching hospital. World J Surg Oncol 2007;5:81. [PMID: 17659085 DOI: 10.1186/1477-7819-5-81] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
302 Glaoui M, Naciri S, Ghanem S, Belkouchi A, Errihani H. [The surgical treatment of adenocarcinoma of the gastroesophageal junction: Moroccan experience through a series of 149 cases]. Pan Afr Med J 2011;8:35. [PMID: 22121443 DOI: 10.4314/pamj.v8i1.71150] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
303 Dulucq JL, Wintringer P, Stabilini C, Solinas L, Perissat J, Mahajna A. Laparoscopic and open gastric resections for malignant lesions: a prospective comparative study. Surg Endosc 2005;19:933-8. [PMID: 15920691 DOI: 10.1007/s00464-004-2172-9] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
304 Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One 2012;7:e49424. [PMID: 23166665 DOI: 10.1371/journal.pone.0049424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
305 Bencivenga M, Torroni L, Verlato G, Mengardo V, Sacco M, Allum WH, de Manzoni G. Lymphadenectomy for gastric cancer at European specialist centres. Eur J Surg Oncol 2021;47:1048-54. [PMID: 33092970 DOI: 10.1016/j.ejso.2020.10.013] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
306 Khushalani N. Cancer of the esophagus and stomach. Mayo Clin Proc. 2008;83:712-722. [PMID: 18533089 DOI: 10.4065/83.6.712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
307 van der Geld YG, Senan S, van Sörnsen de Koste JR, Verbakel WF, Slotman BJ, Lagerwaard FJ. A Four-Dimensional CT-Based Evaluation of Techniques for Gastric Irradiation. International Journal of Radiation Oncology*Biology*Physics 2007;69:903-9. [DOI: 10.1016/j.ijrobp.2007.06.062] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
308 Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17:1267-1277. [PMID: 20099040 DOI: 10.1245/s10434-010-0914-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
309 Huscher CG, Mingoli A, Sgarzini G, Brachini G, Binda B, Di Paola M, Ponzano C. Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early and advanced gastric cancer: early and long-term results of a 100-patient series. Am J Surg. 2007;194:839-844; discussion 844. [PMID: 18005781 DOI: 10.1016/j.amjsurg.2007.08.037] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 6.0] [Reference Citation Analysis]
310 Panin SI, Postolov MP, Kovalenko NV, Beburishvili AG, Fedorov AV, Bykov AV. [Distal subtotal gastrectomy and gastreectomy in surgical treatment of patients with gastric cancer: a systematic review and meta-analysis]. Khirurgiia (Mosk) 2020;:93-100. [PMID: 33210514 DOI: 10.17116/hirurgia202011193] [Reference Citation Analysis]
311 Malmström P. Lymph node staging in prostatic carcinoma revisited. Acta Oncologica 2009;44:593-8. [DOI: 10.1080/02841860510029626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
312 Hartgrink HH. Improving outcome for scirrhous gastric cancer. Gastric Cancer 2009;12:3-5. [PMID: 19390926 DOI: 10.1007/s10120-009-0501-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
313 Povoski SP, Neff RL, Mojzisik CM, O'Malley DM, Hinkle GH, Hall NC, Murrey DA Jr, Knopp MV, Martin EW Jr. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol 2009;7:11. [PMID: 19173715 DOI: 10.1186/1477-7819-7-11] [Cited by in Crossref: 151] [Cited by in F6Publishing: 98] [Article Influence: 12.6] [Reference Citation Analysis]
314 Anderson C, Ellenhorn J, Hellan M, Pigazzi A. Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric cancer. Surg Endosc. 2007;21:1662-1666. [PMID: 17345142 DOI: 10.1007/s00464-007-9266-0] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 6.0] [Reference Citation Analysis]
315 Muratore A, Zimmitti G, Lo Tesoriere R, Mellano A, Massucco P, Capussotti L. Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer. Eur J Surg Oncol. 2009;35:588-592. [PMID: 19162429 DOI: 10.1016/j.ejso.2008.12.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
316 Marrelli D, De Franco L, Iudici L, Polom K, Roviello F. Lymphadenectomy: state of the art. Transl Gastroenterol Hepatol 2017;2:3. [PMID: 28217753 DOI: 10.21037/tgh.2017.01.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
317 Mönig SP, Collet PH, Baldus SE, Schmackpfeffer K, Schröder W, Thiele J, Dienes HP, Hölscher AH. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol. 2001;76:89-92. [PMID: 11223832 DOI: 10.1002/1096-9098(200102)76:2%3C89::AID-JSO1016%3E3.0.CO;2-I] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
318 da Costa WL Jr, Coimbra FJ, Ribeiro HS, Diniz AL, de Godoy AL, de Farias IC, Begnami MD, Soares FA. Total gastrectomy for gastric cancer: an analysis of postoperative and long-term outcomes through time: results of 413 consecutive cases in a single cancer center. Ann Surg Oncol 2015;22:750-7. [PMID: 25366586 DOI: 10.1245/s10434-014-4212-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
319 Moslim MA, Deng M, Handorf E, Greco SH, Farma JM. Optimal care and survival for signet-ring cell and non-signet-ring cell gastric cancer are more achievable at academic cancer centers. Am J Surg 2021:S0002-9610(21)00287-7. [PMID: 34045068 DOI: 10.1016/j.amjsurg.2021.05.007] [Reference Citation Analysis]
320 Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(47): 13294-13301 [PMID: 26715812 DOI: 10.3748/wjg.v21.i47.13294] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
321 Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, Vindigni C, Morgagni P, Saragoni L, de Manzoni G, Tomezzoli A. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol. 2006;94:275-280; discussion 274. [PMID: 16917863 DOI: 10.1002/jso.20566] [Cited by in Crossref: 101] [Cited by in F6Publishing: 97] [Article Influence: 6.7] [Reference Citation Analysis]
322 Thomson IG, Gotley DC, Barbour AP, Martin I, Jayasuria N, Thomas J, Smithers BM. Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes. Gastric Cancer. 2014;17:152-160. [PMID: 23474836 DOI: 10.1007/s10120-013-0240-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
323 Wu XS, Wu WG, Li ML, Yang JH, Ding QC, Zhang L, Mu JS, Gu J, Dong P, Lu JH, Liu YB. Impact of being overweight on the surgical outcomes of patients with gastric cancer: A meta-analysis. World J Gastroenterol 2013; 19(28): 4596-4606 [DOI: 10.3748/wjg.v19.i28.4596] [Reference Citation Analysis]
324 Marcus SG, Cohen D, Lin K, Wong K, Thompson S, Rothberger A, Potmesil M, Hiotis S, Newman E. Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer. J Gastrointest Surg. 2003;7:1015-1022; discussion 1023. [PMID: 14675711 DOI: 10.1016/j.gassur.2003.09.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
325 Lordick F, Stein HJ, Peschel C, Siewert JR. Neoadjuvant therapy for oesophagogastric cancer. Br J Surg. 2004;91:540-551. [PMID: 15122603 DOI: 10.1002/bjs.4575] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
326 Santoro R, Ettorre GM, Santoro E. Subtotal gastrectomy for gastric cancer. World J Gastroenterol 2014; 20(38): 13667-13680 [PMID: 25320505 DOI: 10.3748/wjg.v20.i38.13667] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
327 Zilberstein B, Mucerino DR, Yagi OK, Ribeiro-Junior U, Lopasso FP, Bresciani C, Jacob CE, Coimbra BG, Cecconello I. Results of D2 gastrectomy for gastric cancer: lymph node chain dissection or multiple node resection? Arq Bras Cir Dig 2012;25:161-4. [PMID: 23411804 DOI: 10.1590/s0102-67202012000300005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
328 Hundahl SA, Wanebo HJ. Changing gastric cancer treatment in the United States and the pursuit of quality. Eur J Surg Oncol. 2005;31:605-615. [PMID: 16023944 DOI: 10.1016/j.ejso.2005.02.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
329 Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol 2008; 14(24): 3773-3780 [PMID: 18609699 DOI: 10.3748/wjg.14.3773] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
330 Maezawa Y, Aoyama T, Yamada T, Kano K, Hayashi T, Sato T, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Priority of lymph node dissection for proximal gastric cancer invading the greater curvature. Gastric Cancer 2018;21:569-72. [DOI: 10.1007/s10120-017-0775-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
331 Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Ye X, Swanson RS, Enzinger PC, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, Ciombor K, Berg DJ, Meyerhardt J, Mayer RJ. Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). J Clin Oncol. 2017;35:3671-3677. [PMID: 28976791 DOI: 10.1200/jco.2017.74.2130] [Cited by in Crossref: 62] [Cited by in F6Publishing: 21] [Article Influence: 15.5] [Reference Citation Analysis]
332 Roukos DH. Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol 2004;11:127-9. [PMID: 14761914 DOI: 10.1245/aso.2004.11.903] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
333 Takeuchi H, Kitagawa Y. Is lymphadenectomy a predictor or savior for patients with gastric cancer? Ann Surg Oncol. 2010;17:1257-1258. [PMID: 20140527 DOI: 10.1245/s10434-010-0942-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
334 Roviello F, Rossi S, Marrelli D, De Manzoni G, Pedrazzani C, Morgagni P, Corso G, Pinto E. Perforated gastric carcinoma: a report of 10 cases and review of the literature. World J Surg Oncol 2006;4:19. [PMID: 16573818 DOI: 10.1186/1477-7819-4-19] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
335 Spanknebel KA, Brennan MF. Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention? Surg Oncol Clin N Am. 2002;11:415-30, xii. [PMID: 12424860 DOI: 10.1016/s1055-3207(02)00008-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
336 Giacopuzzi S, Bencivenga M, Cipollari C, Weindelmayer J, de Manzoni G. Lymphadenectomy: how to do it? Transl Gastroenterol Hepatol 2017;2:28. [PMID: 28447063 DOI: 10.21037/tgh.2017.03.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
337 Fugazzola P, Ansaloni L, Sartelli M, Catena F, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Coccolini F. Advanced gastric cancer: the value of surgery. Acta Biomed 2018;89:110-6. [PMID: 30561428 DOI: 10.23750/abm.v89i8-S.7897] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
338 Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. European Journal of Surgical Oncology (EJSO) 2017;43:1350-6. [DOI: 10.1016/j.ejso.2017.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
339 Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21(40): 11428-11438 [PMID: 26523107 DOI: 10.3748/wjg.v21.i40.11428] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 100] [Article Influence: 17.3] [Reference Citation Analysis]
340 Gosselin-Tardif A, Lie J, Nicolau I, Molina JC, Cools-Lartigue J, Feldman L, Spicer J, Mueller C, Ferri L. Gastrectomy with Extended Lymphadenectomy: a North American Perspective. J Gastrointest Surg 2018;22:414-20. [PMID: 29124550 DOI: 10.1007/s11605-017-3633-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
341 Hoeppner J. Chirurgische Strategie in der multimodalen Behandlung des Magen- und Ösophaguskarzinoms. Chirurg 2017;88:1005-9. [DOI: 10.1007/s00104-017-0545-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Ruspi L, Galli F, Pappalardo V, Inversini D, Martignoni F, Boni L, Dionigi G, Rausei S. Lymphadenectomy in elderly/high risk patients: should it be different? Transl Gastroenterol Hepatol 2017;2:5. [PMID: 28217755 DOI: 10.21037/tgh.2016.12.07] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
343 Tee MC, Pirozzi N, Brahmbhatt RD, Raman S, Franko J. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States. Eur J Surg Oncol 2020;46:1941-7. [PMID: 32466860 DOI: 10.1016/j.ejso.2020.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
344 Hallet J, Labidi S, Bouchard-Fortier A, Clairoux A, Gagné JP. Oncologic specimen from laparoscopic assisted gastrectomy for gastric adenocarcinoma is comparable to D1-open surgery: the experience of a Canadian centre. Can J Surg 2013;56:249-55. [PMID: 23883495 DOI: 10.1503/cjs.002612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
345 Wenguang W, Xuefeng W, Zhiping Z, Xiangsong W, Jianwei W, Songgang L, Yingbin L. Three-step method for lymphadenectomy in gastric cancer surgery: a single institution experience of 120 patients. J Am Coll Surg 2011;212:200-8. [PMID: 21276533 DOI: 10.1016/j.jamcollsurg.2010.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
346 Knab LM, Belotte J, Munshi HG, Bentrem DJ. Comparative Effectiveness in Esophagogastric Cancer. In: Bilimoria KY, Minami CA, Mahvi DM, editors. Comparative Effectiveness in Surgical Oncology. Cham: Springer International Publishing; 2015. pp. 121-42. [DOI: 10.1007/978-3-319-12553-4_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
347 Zhang H, Liu C, Wu D, Meng Y, Song R, Lu P, Wang S. Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer A result based on a hospital population of two decades as taking D2 surgery for reference. BMC Cancer. 2010;10:308. [PMID: 20565910 DOI: 10.1186/1471-2407-10-308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
348 Kiyokawa T, Fukagawa T. Recent trends from the results of clinical trials on gastric cancer surgery. Cancer Commun (Lond) 2019;39:11. [PMID: 30917873 DOI: 10.1186/s40880-019-0360-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
349 Wang F, Chang Y, Chen T, Hsu J, Kuo C, Lin C, Chen J, Chiang K, Yeh T, Hwang T, Jan Y. Prognostic significance of splenectomy for patients with gastric adenocarcinoma undergoing total gastrectomy: A retrospective cohort study. International Journal of Surgery 2014;12:557-65. [DOI: 10.1016/j.ijsu.2014.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
350 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2005;54:209-241. [PMID: 15890270 DOI: 10.1016/j.critrevonc.2005.01.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
351 Merrett ND. Multimodality treatment of potentially curative gastric cancer: Geographical variations and future prospects. World J Gastroenterol 2014; 20(36): 12892-12899 [PMID: 25278686 DOI: 10.3748/wjg.v20.i36.12892] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
352 Bugat R. Irinotecan in the treatment of gastric cancer. Ann Oncol 2003;14 Suppl 2:ii37-40. [PMID: 12810456 DOI: 10.1093/annonc/mdg727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
353 Bang Y, Kim Y, Yang H, Chung HC, Park Y, Lee KH, Lee K, Kim YH, Noh S, Cho JY, Mok YJ, Kim YH, Ji J, Yeh T, Button P, Sirzén F, Noh SH. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. The Lancet 2012;379:315-21. [DOI: 10.1016/s0140-6736(11)61873-4] [Cited by in Crossref: 866] [Cited by in F6Publishing: 539] [Article Influence: 96.2] [Reference Citation Analysis]
354 Cohen DJ, Newman E, Iqbal S, Chang RY, Potmesil M, Ryan T, Donahue B, Chandra A, Liu M, Utate M, Hiotis S, Pachter LH, Hochster H, Muggia F. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma. Ann Surg Oncol 2012;19:478-85. [PMID: 21769462 DOI: 10.1245/s10434-011-1940-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
355 Kundel Y, Levitt ML, Oberman B, Sadezki S, Tichler T, Symon Z, Catane R, Pfeffer R, Brenner B. Adjuvant Chemotherapy and Whole Abdominal Irradiation for Gastric Carcinoma. Tumori 2008;94:469-73. [DOI: 10.1177/030089160809400405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y. Is D2 lymph node dissection necessary for early gastric cancer? Ann Surg Oncol. 2002;9:401-405. [PMID: 11986193 DOI: 10.1007/bf02573876] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
357 Coit D. Adjuvant Therapy for Gastric Cancer. Journal of the American College of Surgeons 2007;205:S54-8. [DOI: 10.1016/j.jamcollsurg.2007.06.329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
358 Glehen O, Peyrat P, Beaujard AC, Chapet O, Romestaing P, Sentenac I, Francois Y, Vignal J, Gérard JP, Gilly FN. Pattern of failures in gastric cancer patients with lymph node involvement treated by surgery, intraoperative and external beam radiotherapy. Radiother Oncol. 2003;67:171-175. [PMID: 12812847 DOI: 10.1016/s0167-8140(02)00344-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
359 Mihaljevic AL, Friess H, Schuhmacher C. Clinical trials in gastric cancer and the future. J Surg Oncol 2013;107:289-97. [PMID: 22514058 DOI: 10.1002/jso.23120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
360 Oh DY, Bang YJ. Adjuvant and neoadjuvant therapy for gastric cancer. Curr Treat Options Oncol. 2013;14:311-320. [PMID: 23686725 DOI: 10.1007/s11864-013-0238-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
361 Buffart TE, Carvalho B, van Grieken NC, van Wieringen WN, Tijssen M, Kranenbarg EM, Verheul HM, Grabsch HI, Ylstra B, van de Velde CJ, Meijer GA. Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer. Oncologist 2012;17:653-62. [PMID: 22531355 DOI: 10.1634/theoncologist.2010-0379] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
362 Pemberton L, Coote J, Perry L, Khoo VS, Saunders MP. Adjuvant chemoradiotherapy for gastric carcinoma: dosimetric implications of conventional gastric bed irradiation and toxicity. Clin Oncol (R Coll Radiol). 2006;18:663-668. [PMID: 17100151 DOI: 10.1016/j.clon.2006.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
363 Hughes BGM, Yip D, Chao M, Gibbs P, Carroll S, Goldstein D, Burmeister B, Karapetis C. Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience. ANZ J Surg 2004;74:951-6. [DOI: 10.1111/j.1445-1433.2004.03218.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
364 Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, Roviello F, de Manzoni G, Minicozzi A, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D; Italian Research Group for Gastric Cancer (IRGGC). The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-52. [PMID: 17414602 DOI: 10.1097/01.sla.0000250423.43436.e1] [Cited by in Crossref: 254] [Cited by in F6Publishing: 262] [Article Influence: 18.1] [Reference Citation Analysis]
365 Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069-2077. [PMID: 15082726 DOI: 10.1200/jco.2004.08.026] [Cited by in Crossref: 617] [Cited by in F6Publishing: 261] [Article Influence: 36.3] [Reference Citation Analysis]
366 Degiuli M, Reddavid R, Tomatis M, Ponti A, Morino M, Sasako M; of the Italian Gastric Cancer Study Group (IGCSG). D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial. Eur J Cancer 2021;150:10-22. [PMID: 33887514 DOI: 10.1016/j.ejca.2021.03.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
367 Gretschel S, Christoph F, Bembenek A, Estevez-Schwarz L, Schneider U, Schlag PM. Body mass index does not affect systematic D2 lymph node dissection and postoperative morbidity in gastric cancer patients. Ann Surg Oncol. 2003;10:363-368. [PMID: 12734083 DOI: 10.1245/aso.2003.07.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
368 Datta J, Mcmillan MT, Ecker BL, Karakousis GC, Mamtani R, Plastaras JP, Giantonio BJ, Drebin JA, Dempsey DT, Fraker DL, Roses RE. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis. Annals of Surgery 2016;263:298-305. [DOI: 10.1097/sla.0000000000001360] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
369 Songun I, van de Velde CJ. Optimal surgery for advanced gastric cancer. Expert Rev Anticancer Ther 2009;9:1849-58. [PMID: 19954295 DOI: 10.1586/era.09.132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
370 Uslu A, Bati H, Postaci H, Nart A, Eliyatkin N, Yetis H, Corumlu B, Aykas A, Zengel B. Impact of histopathology on the outcome of D1/D2 gastrectomies with R0 resection. Digestion 2012;86:67-73. [PMID: 22777320 DOI: 10.1159/000338298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
371 Roggin KK, Hemmerich J, Posner MC. Extended follow-up after extended lymphadenectomy for gastric cancer: was it worth the wait? Lancet Oncol 2010;11:404-5. [PMID: 20409753 DOI: 10.1016/S1470-2045(10)70098-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
372 Valentini V, Cellini F. Radiotherapy in gastric cancer: a systematic review of literature and new perspectives. Expert Rev Anticancer Ther 2007;7:1379-93. [PMID: 17944564 DOI: 10.1586/14737140.7.10.1379] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
373 Tamura S, Takeno A, Miki H. Lymph node dissection in curative gastrectomy for advanced gastric cancer. Int J Surg Oncol. 2011;2011:748745. [PMID: 22312521 DOI: 10.1155/2011/748745] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
374 Foo M, Crosby T, Rackley T, Leong T. Role of (chemo)-radiotherapy in resectable gastric cancer. Clin Oncol (R Coll Radiol). 2014;26:541-550. [PMID: 24996375 DOI: 10.1016/j.clon.2014.06.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
375 Kumagai K, Hiki N, Nunobe S, Irino T, Ida S, Ohashi M, Yamaguchi T, Sano T. Metastasis to the lymph nodes along the proper hepatic artery from adenocarcinoma of the stomach. Langenbecks Arch Surg 2016;401:677-85. [PMID: 27086307 DOI: 10.1007/s00423-016-1429-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
376 Spathis A, Georgoulakis J, Foukas P, Kefala M, Leventakos K, Machairas A, Panayiotides I, Karakitsos P. KRAS and BRAF mutation analysis from liquid-based cytology brushings of colorectal carcinoma in comparison with formalin-fixed, paraffin-embedded tissue. Anticancer Res. 2010;30:1969-1975. [PMID: 20651341 DOI: 10.1097/cad.0b013e328338b6a5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
377 Gunderson LL, Tepper JE, Calvo FA, Callister MD. Gastric/GE Junction Cancer. Clinical Radiation Oncology. Elsevier; 2012. pp. 903-33. [DOI: 10.1016/b978-1-4377-1637-5.00045-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
378 Okajima W, Komatsu S, Ichikawa D, Kosuga T, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol 2016;31:1566-71. [PMID: 26840392 DOI: 10.1111/jgh.13306] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
379 Popiela T, Kulig J, Kolodziejczyk P, Sierzega M. Long-term results of surgery for early gastric cancer. Br J Surg. 2002;89:1035-1042. [PMID: 12153632 DOI: 10.1046/j.1365-2168.2002.02156.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
380 Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010;56:e1-48. [PMID: 20207771 DOI: 10.1373/clinchem.2009.133124] [Cited by in Crossref: 146] [Cited by in F6Publishing: 119] [Article Influence: 13.3] [Reference Citation Analysis]
381 Miki Y, Tokunaga M, Bando E, Tanizawa Y, Kawamura T, Terashima M. Evaluation of postoperative pancreatic fistula after total gastrectomy with D2 lymphadenectomy by ISGPF classification. J Gastrointest Surg. 2011;15:1969-1976. [PMID: 21833745 DOI: 10.1007/s11605-011-1628-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
382 Qin HL, Lin CH, Zhang XL. Evaluation of intraoperative radiotherapy for gastric carcinoma with D2 and D3 surgical resection. World J Gastroenterol 2006; 12(43): 7033-7037 [PMID: 17109501 DOI: 10.3748/wjg.v12.i43.7033] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
383 Moslim MA, Handorf E, Reddy SS, Greco SH, Farma JM. Partial Gastrectomy is Associated with Improved Overall Survival in Signet-Ring Cell Gastric Cancer. J Surg Res 2021;266:27-34. [PMID: 33975027 DOI: 10.1016/j.jss.2021.04.005] [Reference Citation Analysis]
384 Mingol F, Gallego J, Orduña A, Martinez-Blasco A, Sola-Vera J, Moya P, Morcillo MA, Ruiz JA, Calpena R, Lacueva FJ. Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction. BMC Surg 2015;15:66. [PMID: 25997454 DOI: 10.1186/s12893-015-0054-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
385 Brar SS, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N. A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S89-S99. [PMID: 21915699 DOI: 10.1007/s10120-011-0087-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
386 Mocan L. Surgical Management of Gastric Cancer: A Systematic Review. J Clin Med 2021;10:2557. [PMID: 34207898 DOI: 10.3390/jcm10122557] [Reference Citation Analysis]
387 Morgagni P, Tringali D, La Barba G, Vittimberga G, Ercolani G. Historical assumptions of lymphadenectomy. Transl Gastroenterol Hepatol 2016;1:90. [PMID: 28138655 DOI: 10.21037/tgh.2016.11.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
388 Patriti A, Ceccarelli G, Bellochi R, Bartoli A, Spaziani A, Di Zitti L, Casciola L. Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma. Surg Endosc 2008;22:2753-60. [PMID: 18813994 DOI: 10.1007/s00464-008-0129-0] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 6.7] [Reference Citation Analysis]
389 Zhang Z, Huang JY, Wang PL, Hou WB, Yin SC, Xu HM. Should All Stage N3b Patients with Advanced Gastric Cancer Be Considered Equivalent? A 30-Year Single Center Study. J Gastrointest Surg 2019;23:1742-7. [PMID: 30238247 DOI: 10.1007/s11605-018-3945-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
390 Choi YY, An JY, Katai H, Seto Y, Fukagawa T, Okumura Y, Kim DW, Kim HI, Cheong JH, Hyung WJ, Noh SH. A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems. PLoS One 2016;11:e0149555. [PMID: 26967161 DOI: 10.1371/journal.pone.0149555] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
391 Lacueva J, Perez-Ramos M, Soto JL, Oliver I, Andrada E, Medrano J, Perez-Vazquez T, Arroyo A, Carrato A, Ferragut JA. Multidrug resistance-associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real-time quantitative RT-PCR. Histopathology. 2005;46:389-395. [PMID: 15810950 DOI: 10.1111/j.1365-2559.2005.02100.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
392 Wohnrath DR, Araujo RLC. Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival. J Surg Oncol 2020;121:777-83. [PMID: 31691299 DOI: 10.1002/jso.25755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
393 Danielson H, Kokkola A, Kiviluoto T, Sirén J, Louhimo J, Kivilaakso E, Puolakkainen P. Clinical Outcome after D1 vs D2–3 Gastrectomy for Treatment of Gastric Cancer. Scand J Surg 2007;96:35-40. [DOI: 10.1177/145749690709600107] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
394 Pretz JL, Wo JY, Mamon HJ, Kachnic LA, Hong TS. Chemoradiation therapy: localized esophageal, gastric, and pancreatic cancer. Surg Oncol Clin N Am 2013;22:511-24. [PMID: 23622077 DOI: 10.1016/j.soc.2013.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
395 Kim Y, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH. Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial. J Gastric Cancer 2018;18:348-55. [PMID: 30607298 DOI: 10.5230/jgc.2018.18.e34] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
396 Sendler A. [Tumors of the upper gastro-intestinal tract]. Chirurg 2010;81:103-6; 108-10. [PMID: 20076935 DOI: 10.1007/s00104-009-1813-x] [Reference Citation Analysis]
397 Meyer HJ, Wilke H. Treatment strategies in gastric cancer. Dtsch Arztebl Int. 2011;108:698-705; quiz 706. [PMID: 22114638 DOI: 10.3238/arztebl.2011.0698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 34] [Article Influence: 0.3] [Reference Citation Analysis]
398 Kim JA, Lee J, Han B, Park SH, Park JO, Park YS, Lim HY, Kang WK. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer. Cancer Chemother Pharmacol 2011;68:177-84. [PMID: 20878159 DOI: 10.1007/s00280-010-1452-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
399 Jiao XG, Deng JY, Zhang RP, Wu LL, Wang L, Liu HG, Hao XS, Liang H. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol 2014; 20(13): 3640-3648 [PMID: 24707149 DOI: 10.3748/wjg.v20.i13.3640] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
400 Baeza MR, Osvaldo Giannini T, Raúl Rivera S, González P, González J, Vergara E, del Castillo C, Madrid J, Vinés E. Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer. International Journal of Radiation Oncology*Biology*Physics 2001;50:645-50. [DOI: 10.1016/s0360-3016(01)01467-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
401 Zhang H, Li X, Wu J, Zhang J, Huang H, Li Y, Li M, Wang S, Xia J, Qi L, Chen T, Ao L. A qualitative transcriptional signature of recurrence risk for stages II-III gastric cancer patients after surgical resection. J Gastroenterol Hepatol 2021. [PMID: 33565610 DOI: 10.1111/jgh.15439] [Reference Citation Analysis]
402 Munene G, Francis W, Garland SN, Pelletier G, Mack LA, Bathe OF. The quality of life trajectory of resected gastric cancer. J Surg Oncol. 2012;105:337-341. [PMID: 22095440 DOI: 10.1002/jso.22139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
403 Makris EA, Poultsides GA. Surgical Considerations in the Management of Gastric Adenocarcinoma. Surg Clin North Am 2017;97:295-316. [PMID: 28325188 DOI: 10.1016/j.suc.2016.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
404 Chen T, Yan D, Zheng Z, Yang J, Dong XDE. Evolution in the surgical management of gastric cancer: is extended lymph node dissection back in vogue in the USA? World J Surg Oncol. 2017;15:135. [PMID: 28716043 DOI: 10.1186/s12957-017-1204-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
405 Disiena MR, Taneja C, Wanebo HJ. Radical Gastrectomy and Lymphadenectomy: Historic Overview, Surgical Trends, and Lessons from the Past. Surgical Oncology Clinics of North America 2005;14:511-32. [DOI: 10.1016/j.soc.2005.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
406 Xu D, Huang Y, Geng Q, Guan Y, Li Y, Wang W, Yuan S, Sun X, Chen Y, Li W, Zhou Z, Zhan Y. Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One 2012;7:e38681. [PMID: 22723875 DOI: 10.1371/journal.pone.0038681] [Cited by in Crossref: 28] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
407 Roy MK, Sadhu S, Dubey SK. Advances in the management of gastric cancer. Indian J Surg. 2009;71:342-349. [PMID: 23133189 DOI: 10.1007/s12262-009-0092-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
408 Omejc M, Mekicar J. Role of computer analysis in gastric cancer surgery: evaluation of the WinEstimate v. 2.5 computer program. World J Surg. 2004;28:59-62. [PMID: 14648044 DOI: 10.1007/s00268-003-7007-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
409 Mulder KE, Ahmed S, Davies JD, Doll CM, Dowden S, Gill S, Gordon V, Hebbard P, Lim H, McFadden A, McGhie JP, Park J, Wong R. Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11-12 September 2015. Curr Oncol. 2016;23:425-434. [PMID: 28050139 DOI: 10.3747/co.23.3384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
410 Nakajima T. Historical Review of Research and Treatment of Gastric Cancer in Japan: Clinical Aspect. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 29-47. [DOI: 10.1007/4-431-27713-7_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
411 Saka M, Morita S, Fukagawa T, Katai H. Present and future status of gastric cancer surgery. Jpn J Clin Oncol. 2011;41:307-313. [PMID: 21242182 DOI: 10.1093/jjco/hyq240] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
412 Lee WJ. It is still not the time to change surgical strategy for gastric cancer. Ann Surg Oncol 2005;12:194; author reply 194-6. [PMID: 15827803 DOI: 10.1245/ASO.2005.10.908] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
413 Hundahl SA. Surgical quality control in gastric cancer trials. Surg Oncol Clin N Am 2002;11:445-58. [PMID: 12424862 DOI: 10.1016/s1055-3207(02)00014-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
414 Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Szczepanik A; Polish Gastric Cancer Study Group. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg. 2007;193:10-15. [PMID: 17188080 DOI: 10.1016/j.amjsurg.2006.04.018] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
415 Coimbra FJF, de Jesus VHF, Franco CP, Calsavara VF, Ribeiro HSC, Diniz AL, de Godoy AL, de Farias IC, Riechelmann RP, Begnami MDFS, da Costa WL. Predicting overall and major postoperative morbidity in gastric cancer patients. J Surg Oncol. 2019;120:1371-1378. [PMID: 31696512 DOI: 10.1002/jso.25743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
416 Hartgrink HH, Bonenkamp HJ, van de Velde CJ. Influence of Surgery on Outcomes in Gastric Cancer. Surgical Oncology Clinics of North America 2000;9:97-117. [DOI: 10.1016/s1055-3207(18)30171-6] [Cited by in Crossref: 24] [Article Influence: 1.1] [Reference Citation Analysis]
417 Lo CH, Chen JH, Wu CW, Lo SS, Hsieh MC, Lui WY. Risk factors and management of intra-abdominal infection after extended radical gastrectomy. Am J Surg 2008;196:741-5. [PMID: 18954604 DOI: 10.1016/j.amjsurg.2007.11.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
418 Villano AM, Zeymo A, Mcdermott J, Crocker A, Zeck J, Chan KS, Shara N, Kim S, Al-refaie WB. Evaluating Dissemination of Adequate Lymphadenectomy for Gastric Cancer in the USA. J Gastrointest Surg 2019;23:2119-28. [DOI: 10.1007/s11605-019-04138-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
419 Zhou ML, Kang M, Li GC, Guo XM, Zhang Z. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis. World J Surg Oncol 2016;14:209. [PMID: 27502921 DOI: 10.1186/s12957-016-0957-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
420 Sasako M. Progress in the treatment of gastric cancer in Japan over the last 50 years. Ann Gastroenterol Surg 2020;4:21-9. [PMID: 32021955 DOI: 10.1002/ags3.12306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
421 Dikken JL, van Sandick JW, Maurits Swellengrebel HA, Lind PA, Putter H, Jansen EP, Boot H, van Grieken NC, van de Velde CJ, Verheij M, Cats A. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer 2011;11:329. [PMID: 21810227 DOI: 10.1186/1471-2407-11-329] [Cited by in Crossref: 136] [Cited by in F6Publishing: 137] [Article Influence: 13.6] [Reference Citation Analysis]
422 Sugisawa N, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer 2012;15:206-12. [PMID: 21993853 DOI: 10.1007/s10120-011-0099-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
423 Theuer CP, Al-kuran R, Akiyama Y, Okumura M, Ziogas A, Carpenter PM. Increased Epithelial Cadherin Expression among Japanese Intestinal-Type Gastric Cancers Compared with Specimens from American Patients of European Descent. The American Surgeon 2006;72:332-8. [DOI: 10.1177/000313480607200412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
424 Powell AG, Hughes DL, Wheat JR, Lewis WG. The 100 most influential manuscripts in gastric cancer: A bibliometric analysis. International Journal of Surgery 2016;28:83-90. [DOI: 10.1016/j.ijsu.2016.02.028] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
425 Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D'Ugo D. Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol 2008;34:519-24. [PMID: 17624713 DOI: 10.1016/j.ejso.2007.05.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
426 Narayan RR, Poultsides GA. Advances in the surgical management of gastric and gastroesophageal junction cancer. Transl Gastroenterol Hepatol 2021;6:16. [PMID: 33409410 DOI: 10.21037/tgh.2020.02.06] [Reference Citation Analysis]
427 Nienhüser H, Schmidt T. Gastric cancer lymph node resection-the more the merrier? Transl Gastroenterol Hepatol 2018;3:1. [PMID: 29441366 DOI: 10.21037/tgh.2017.12.08] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
428 Alkhaffaf B, Blazeby JM, Williamson PR, Bruce IA, Glenny AM. Reporting of outcomes in gastric cancer surgery trials: a systematic review. BMJ Open 2018;8:e021796. [PMID: 30337308 DOI: 10.1136/bmjopen-2018-021796] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
429 Merchant SJ, Li L, Kim J. Racial and ethnic disparities in gastric cancer outcomes: More important than surgical technique? World J Gastroenterol 2014; 20(33): 11546-11551 [PMID: 25206261 DOI: 10.3748/wjg.v20.i33.11546] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
430 Vadthya G, Ramakrishnaiah VPN, Krishnamachari S. Short-Term Outcome in Patients Undergoing Gastrectomy with D2 Lymphadenectomy for Carcinoma Stomach. Indian J Surg Oncol 2017;8:304-11. [DOI: 10.1007/s13193-017-0620-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
431 Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, Manzoni GD. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014; 20(36): 12883-12891 [PMID: 25278685 DOI: 10.3748/wjg.v20.i36.12883] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
432 Ryun Park S. Management of gastric cancer: East vs west. Current Problems in Cancer 2015;39:315-41. [DOI: 10.1016/j.currproblcancer.2015.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
433 Van Laethem JL, Demols A. Adjuvant therapy in gastric and cardia cancer: should we irradiate? Curr Opin Oncol 2006;18:381-5. [PMID: 16721135 DOI: 10.1097/01.cco.0000228746.95035.6c] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
434 Minarich MJ, Schwarz RE. A Simplified Two-Step Technique for Extended Lymphadenectomy During Resection of Gastroesophageal Malignancy: Early Results Compared to En Bloc Dissection. J Gastrointest Surg 2019;23:393-401. [PMID: 30603860 DOI: 10.1007/s11605-018-4056-7] [Reference Citation Analysis]
435 Jung YJ, Seo HS, Kim JH, Park CH, Lee HH. The Relevance of Serosal Exposure Without Nodal Metastasis in Resectional Gastric Cancer. Ann Surg Oncol 2019;26:1772-8. [PMID: 30767177 DOI: 10.1245/s10434-019-07221-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
436 Memon MA, Khan S, Yunus RM, Barr R, Memon B. Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma. Surg Endosc 2008;22:1781-9. [DOI: 10.1007/s00464-008-9925-9] [Cited by in Crossref: 135] [Cited by in F6Publishing: 121] [Article Influence: 10.4] [Reference Citation Analysis]
437 Wu P, Wang P, Ma B, Yin S, Tan Y, Hou W, Wang Z, Xu H, Zhu Z. Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis. Cancer Manag Res 2018;10:4759-71. [PMID: 30464590 DOI: 10.2147/CMAR.S179368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
438 Chen QY, Zhong Q, Liu ZY, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Li P, Zheng CH, Huang CM. Does Noncompliance in Lymph Node Dissection Affect Oncological Efficacy in Gastric Cancer Patients Undergoing Radical Gastrectomy? Ann Surg Oncol 2019;26:1759-71. [PMID: 30756329 DOI: 10.1245/s10434-019-07217-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
439 Sun W, Deng J, Zhang N, Liu H, Liu J, Gu P, Du Y, Wu Z, He W, Wang P, Liang H. Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis. Chin J Cancer Res 2020;32:51-61. [PMID: 32194305 DOI: 10.21147/j.issn.1000-9604.2020.01.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
440 Glehen O, Traverse-Glehen A, Peyrat P, François Y, Gérard JP, Vignal J, Gilly FN. [Stomach adenocarcinoma. Evolution of surgical treatment in a series of 350 cases]. Ann Chir. 2000;125:744-751. [PMID: 11105346 DOI: 10.1016/s0003-3944(00)00268-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
441 Cho J, Park I, Lee D, Sung K, Baek J, Lee J. Advanced Gastric Cancer Perforation Mimicking Abdominal Wall Abscess.J Gastric Cancer. 2015;15:214-217. [PMID: 26468420 DOI: 10.5230/jgc.2015.15.3.214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
442 Roukos DH, Kappas AM. Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 2002;81:59-62; discussion 62. [PMID: 12355403 DOI: 10.1002/jso.10153] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
443 Cao S, Zhou Y, Chen D, Niu Z, Wang D, Lv L, Li Y. Intensive versus conventional insulin therapy in nondiabetic patients receiving parenteral nutrition after D2 gastrectomy for gastric cancer: a randomized controlled trial. J Gastrointest Surg 2011;15:1961-8. [PMID: 21904964 DOI: 10.1007/s11605-011-1654-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
444 Jansen EP, Boot H, Dubbelman R, Bartelink H, Cats A, Verheij M. Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer 2007;97:712-6. [PMID: 17848909 DOI: 10.1038/sj.bjc.6603965] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
445 Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, Zhou ZW, Chen YB, Sun XW, Chen G, Liu Q. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319-326. [PMID: 19050970 DOI: 10.1245/s10434-008-0240-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
446 Ramos MFKP, Pereira MA, Dias AR, Yagi OK, Zaidan EP, Ribeiro-Júnior U, Zilberstein B, Cecconello I. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions. Eur J Surg Oncol 2019;45:460-5. [PMID: 30497814 DOI: 10.1016/j.ejso.2018.11.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
447 Mansour JC, Coit DG. Appropriate Treatment for Patients with Gastric Adenocarcinoma. Ann Surg Oncol 2008;15:1798-9. [DOI: 10.1245/s10434-008-9854-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
448 Date R, Panesar K. D2 gastrectomy - a safe operation in experienced hands*: Total Gastrectomy for Gastric Cancer. International Journal of Clinical Practice 2005;59:672-4. [DOI: 10.1111/j.1742-1241.2004.00413.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
449 Wong J, Jackson P. Gastric cancer surgery: an American perspective on the current options and standards. Curr Treat Options Oncol. 2011;12:72-84. [PMID: 21274666 DOI: 10.1007/s11864-010-0136-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
450 Liu X, Liu Z, Lin E, Chen Y, Sun X, Zhou Z. A cumulative score based on preoperative fibrinogen and the neutrophil-lymphocyte ratio to predict outcomes in resectable gastric cancer. Cancer Manag Res 2018;10:3007-14. [PMID: 30214295 DOI: 10.2147/CMAR.S174656] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
451 Rausei S, Dionigi G, Rovera F, Boni L, Valerii C, Giavarini L, Frattini F, Dionigi R. A decade in gastric cancer curative surgery: Evidence of progress (1999-2009). World J Gastrointest Surg 2012; 4(3): 45-54 [PMID: 22530078 DOI: 10.4240/wjgs.v4.i3.45] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
452 Moehler M, Galle PR, Gockel I, Junginger T, Schmidberger H. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer. Best Pract Res Clin Gastroenterol 2007;21:965-81. [PMID: 18070698 DOI: 10.1016/j.bpg.2007.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
453 Gretschel S, Estevez-Schwarz L, Hünerbein M, Schneider U, Schlag PM. Gastric cancer surgery in elderly patients. World J Surg. 2006;30:1468-1474. [PMID: 16850149 DOI: 10.1007/s00268-005-0633-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
454 Panzeri F, Marchegiani G, Malleo G, Malpaga A, Maggino L, Marchese T, Salvia R, Bassi C, Butturini G. Distal pancreatectomy associated with multivisceral resection: results from a single centre experience. Langenbecks Arch Surg 2017;402:457-64. [DOI: 10.1007/s00423-016-1514-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
455 Smalley SR, Gunderson L, Tepper J, Martenson JA, Minsky B, Willett C, Rich T. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys. 2002;52:283-293. [PMID: 11872272 DOI: 10.1016/s0360-3016(01)02646-3] [Cited by in Crossref: 125] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
456 Lemmens VE, Dassen AE, van der Wurff AA, Coebergh JW, Bosscha K. Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol. 2011;37:488-496. [PMID: 21444177 DOI: 10.1016/j.ejso.2011.03.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
457 Mack LA. D1 versus D2 lymphadenectomy and volume versus training: ongoing debate in gastric cancer surgery. J Surg Oncol 2006;93:345-6. [PMID: 16550554 DOI: 10.1002/jso.20496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
458 Maehara Y, Kakeji Y, Oda S, Takahashi I, Akazawa K, Sugimachi K. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer. 2000;83:986-991. [PMID: 10993643 DOI: 10.1054/bjoc.2000.1427] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 3.3] [Reference Citation Analysis]
459 Allum WH, Smyth EC, Blazeby JM, Grabsch HI, Griffin SM, Rowley S, Cafferty FH, Langley RE, Cunningham D. Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction. Br J Surg 2019;106:1204-15. [PMID: 31268180 DOI: 10.1002/bjs.11184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
460 Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2007;14:317-328. [PMID: 17094022 DOI: 10.1245/s10434-006-9218-2] [Cited by in Crossref: 155] [Cited by in F6Publishing: 161] [Article Influence: 10.3] [Reference Citation Analysis]
461 Catarci M, Montemurro LA, Ghinassi S, Di Cintio A, Leone L, Cosentino LM, Viarengo MA, Grassi GB. Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer. Updates Surg. 2011;63:83-90. [PMID: 21445644 DOI: 10.1007/s13304-011-0065-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
462 Verlato G, Roviello F, Marchet A, Giacopuzzi S, Marrelli D, Nitti D, de Manzoni G. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594-602. [PMID: 19118437 DOI: 10.1245/s10434-008-0271-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
463 Dikken JL, van Sandick JW, Maurits Swellengrebel HA, Lind PA, Putter H, Jansen EP, Boot H, van Grieken NC, van de Velde CJ, Verheij M. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer. 2011;11:329. [PMID: 21810227 DOI: 10.1186/1471-2047.11-329] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
464 Sasako M. Surgery and adjuvant chemotherapy. Int J Clin Oncol. 2008;13:193-195. [PMID: 18553226 DOI: 10.1007/s10147-008-0791-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
465 Doekhie FS, Mesker WE, van Krieken JH, Kok NF, Hartgrink HH, Kranenbarg EK, Putter H, Kuppen PJ, Tanke HJ, Tollenaar RA. Clinical relevance of occult tumor cells in lymph nodes from gastric cancer patients. Am J Surg Pathol. 2005;29:1135-1144. [PMID: 16096401 DOI: 10.1097/01.pas.0000160439.38770.cb] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
466 Hartgrink HH, van de Velde CJ. Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005;90:153-65. [DOI: 10.1002/jso.20222] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
467 Lin GT, Chen QY, Zhong Q, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Huang CM. Intraoperative Surrogate Indicators of Gastric Cancer Patients' Long-Term Prognosis: The Number of Lymph Nodes Examined Relates to the Lymph Node Noncompliance Rate. Ann Surg Oncol 2020;27:3281-93. [PMID: 32212034 DOI: 10.1245/s10434-020-08387-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
468 Ma BB, Hui EP, Mok TS. Population-based differences in treatment outcome following anticancer drug therapies. Lancet Oncol. 2010;11:75-84. [PMID: 20129130 DOI: 10.1016/s1470-2045(09)70160-3] [Cited by in Crossref: 93] [Cited by in F6Publishing: 44] [Article Influence: 8.5] [Reference Citation Analysis]
469 Lou N, Zhang L, Chen XD, Pang WY, Arvine C, Huang YP, Zhuang CL, Shen X. A novel scoring system associating with preoperative platelet/lymphocyte and clinicopathologic features to predict lymph node metastasis in early gastric cancer. J Surg Res 2017;209:153-61. [PMID: 28032552 DOI: 10.1016/j.jss.2016.10.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
470 Chen XZ, Hu JK, Zhou ZG, Rui YY, Yang K, Wang L, Zhang B, Chen ZX, Chen JP. Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer. J Am Coll Surg. 2010;210:100-105. [PMID: 20123339 DOI: 10.1016/j.jamcollsurg.2009.09.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
471 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 24(2): 274-289 [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 26] [Article Influence: 12.7] [Reference Citation Analysis]
472 Kim MC, Kim SY, Kim KW. Laparoscopic Reinforcement Suture (LARS) on Staple Line of Duodenal Stump Using Barbed Suture in Laparoscopic Gastrectomy for Gastric Cancer: a Prospective Single Arm Phase II Study. J Gastric Cancer 2017;17:354-62. [PMID: 29302375 DOI: 10.5230/jgc.2017.17.e40] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
473 Yuasa N, Nimura Y. Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival. Langenbecks Arch Surg. 2005;390:286-293. [PMID: 15133674 DOI: 10.1007/s00423-004-0482-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
474 Bollschweiler EH, Mönig SP, Hensler K, Baldus SE, Maruyama K, Hölscher AH. Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study. Ann Surg Oncol. 2004;11:506-511. [PMID: 15123460 DOI: 10.1245/aso.2004.04.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
475 Zhang YX, Yang K. Significance of nodal dissection and nodal positivity in gastric cancer. Transl Gastroenterol Hepatol 2020;5:17. [PMID: 32258521 DOI: 10.21037/tgh.2019.09.13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
476 Abdelfatah MM, Gochanour EM. Fiducial placement for recurrent gastric cancer. Arab J Gastroenterol 2019;20:56-8. [PMID: 30745013 DOI: 10.1016/j.ajg.2019.01.007] [Reference Citation Analysis]
477 Kasakura Y, Fujii M, Mochizuki F, Kochi M, Kaiga T. Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer? Am J Surg. 2000;179:237-242. [PMID: 10827328 DOI: 10.1016/s0002-9610(00)00293-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
478 Schumacher SE, Shim BY, Corso G, Ryu MH, Kang YK, Roviello F, Saksena G, Peng S, Shivdasani RA, Bass AJ, Beroukhim R. Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients. PLoS One 2017;12:e0176045. [PMID: 28426752 DOI: 10.1371/journal.pone.0176045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
479 Quiros RM, Bui CL. Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 2009;89:79-96, viii. [PMID: 19186232 DOI: 10.1016/j.suc.2008.09.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
480 Miura S, Kodera Y, Fujiwara M, Ito S, Mochizuki Y, Yamamura Y, Hibi K, Ito K, Akiyama S, Nakao A. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg 2004;198:933-8. [PMID: 15194075 DOI: 10.1016/j.jamcollsurg.2004.01.021] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
481 Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Lymphadenectomy for Adenocarcinoma of the Gastroesophageal Junction (GEJ): Impact of Adequate Staging on Outcome. Ann Surg Oncol 2007;14:306-16. [DOI: 10.1245/s10434-006-9166-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
482 Smith BR, Stabile BE. Aggressive D2 Lymphadenectomy is Required for Accurate Pathologic Staging of Gastric Adenocarcinoma. The American Surgeon 2006;72:849-52. [DOI: 10.1177/000313480607201001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
483 RC 2nd, Jaques DP, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg. 2002;236:159-165. [PMID: 12170020 DOI: 10.1097/00000658-200208000-00003] [Cited by in Crossref: 148] [Cited by in F6Publishing: 130] [Article Influence: 7.8] [Reference Citation Analysis]
484 Terashima M. The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot. Ann Gastroenterol Surg 2021;5:270-7. [PMID: 34095716 DOI: 10.1002/ags3.12442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 Scartozzi M, Galizia E, Graziano F, Catalano V, Berardi R, Baldelli AM, Testa E, Mari D, Silva RR, Cascinu S. Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients. Br J Cancer 2005;92:1051-4. [PMID: 15770210 DOI: 10.1038/sj.bjc.6602468] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
486 Roukos DH, Paraschou P, Lorenz M. Distal Gastric Cancer and Extensive Surgery: A New Evaluation Method Based on the Study of the Status of Residual Lymph Nodes After Limited Surgery. Ann Surg Oncol 2000;7:719-26. [DOI: 10.1007/s10434-000-0719-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
487 Goto H, Yasuda T, Oshikiri T, Kanaji S, Kawasaki K, Imanishi T, Oyama M, Kakinoki K, Ohara T, Sendo H, Fujino Y, Tominaga M, Kakeji Y. Comparing the short-term outcomes of laparoscopic distal gastrectomy with D1+ and D2 lymph node dissection for gastric cancer: LDG with D1 and D2 lymph node dissection. Asian J Endosc Surg 2016;9:116-21. [DOI: 10.1111/ases.12269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
488 Montgomery M, Fukuhara S, Karpeh M, Brower S. Evidence-based review of the management of early gastric cancer. Gastroenterol Rep (Oxf) 2013;1:105-12. [PMID: 24759815 DOI: 10.1093/gastro/got016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
489 Lawrence W. Gastric Adenocarcinoma. Curr Treat Options Gastroenterol 2004;7:149-57. [PMID: 15010029 DOI: 10.1007/s11938-004-0036-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
490 Luna A, Rebasa P, Montmany S, Navarro S. Learning curve for d2 Lymphadenectomy in gastric cancer. ISRN Surg. 2013;2013:508719. [PMID: 23844296 DOI: 10.1155/2013/508719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
491 Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Lirici MM, Napolitano C, Piro F. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer. Am J Surg. 2004;188:728-735. [PMID: 15619491 DOI: 10.1016/j.amjsurg.2004.08.040] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
492 Fujita T, Ohta M, Ozaki Y, Takahashi Y, Miyazaki S, Harada T, Iino I, Kikuchi H, Hiramatsu Y, Kamiya K, Konno H. Collateral thermal damage to the pancreas by ultrasonic instruments during lymph node dissection in laparoscopic gastrectomy. Asian J Endosc Surg 2015;8:281-8. [PMID: 25706186 DOI: 10.1111/ases.12177] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
493 Mocellin S, Nitti D. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. Cancer Treat Rev 2015;41:448-54. [PMID: 25814393 DOI: 10.1016/j.ctrv.2015.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
494 An JY, Pak KH, Inaba K, Cheong JH, Hyung WJ, Noh SH. Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer. Br J Surg. 2011;98:667-672. [PMID: 21294111 DOI: 10.1002/bjs.7414] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
495 McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. BMJ. 2002;324:1448-1451. [PMID: 12065273 DOI: 10.1136/bmj.324.7351.1448] [Cited by in Crossref: 458] [Cited by in F6Publishing: 390] [Article Influence: 24.1] [Reference Citation Analysis]
496 Jansen EP, Boot H, Verheij M, van de Velde CJ. Optimal locoregional treatment in gastric cancer. J Clin Oncol. 2005;23:4509-4517. [PMID: 16002841 DOI: 10.1200/JCO.2005.21.196] [Cited by in Crossref: 70] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
497 Karavokyros I, Michalinos A. Favoring D2-Lymphadenectomy in Gastric Cancer. Front Surg 2018;5:42. [PMID: 29930941 DOI: 10.3389/fsurg.2018.00042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
498 Marano L, Marrelli D, Roviello F. Focus on research: Nodal dissection for gastric cancer - A dilemma worthy of King Solomon! Eur J Surg Oncol 2016;42:1623-4. [PMID: 27554248 DOI: 10.1016/j.ejso.2016.07.143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
499 李鹏, 何晓东, 田金徽, 杨克虎, 姜雷. 全胃联合脾切除治疗进展期胃癌的系统评价. 世界华人消化杂志 2009; 17(12): 1241-1246 [DOI: 10.11569/wcjd.v17.i12.1241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
500 Mogal H, Fields R, Maithel SK, Votanopoulos K. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3? Ann Surg Oncol. 2019;26:2912-2932. [PMID: 31076930 DOI: 10.1245/s10434-019-07417-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
501 Zhao L, Niu P, Zhao D, Chen Y. Regional and racial disparity in proximal gastric cancer survival outcomes 1996-2016: Results from SEER and China National Cancer Center database. Cancer Med 2021;10:4923-38. [PMID: 34105890 DOI: 10.1002/cam4.4033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
502 Roukos DH, Kappas AM. Limitations in controlling risk for recurrence after curative surgery for advanced gastric cancer are now well-explained by molecular-based mechanisms. Ann Surg Oncol 2001;8:620-1. [PMID: 11569774 DOI: 10.1007/s10434-001-0620-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
503 Bolton JS, Teng S. Transthoracic or transhiatal esophagectomy for cancer of the esophagus—does it matter? Surgical Oncology Clinics of North America 2002;11:365-75. [DOI: 10.1016/s1055-3207(02)00012-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
504 Kobayakawa M, Kojima Y. Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies. Onco Targets Ther. 2011;4:193-201. [PMID: 22162925 DOI: 10.2147/ott.s19059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
505 Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease--part II. Curr Probl Surg 2005;42:796-862. [PMID: 16344044 DOI: 10.1067/j.cpsurg.2005.08.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
506 Singh KK, Rohatgi A, Rybinkina I, McCulloch P, Mudan S. Laparoscopic gastrectomy for gastric cancer: early experience among the elderly. Surg Endosc 2008;22:1002-7. [PMID: 17768658 DOI: 10.1007/s00464-007-9561-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
507 Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, Roviello F, Morgagni P, Saragoni L, Natalini G. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159-165. [PMID: 17566691 DOI: 10.1016/j.ejso.2007.04.018] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 5.5] [Reference Citation Analysis]
508 Allum WH, Griffin SM, Watson A, Colin-Jones D; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland., British Society of Gastroenterology., British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut 2002;50 Suppl 5:v1-23. [PMID: 12049068 DOI: 10.1136/gut.50.90005.v1] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
509 Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727 [PMID: 25320509 DOI: 10.3748/wjg.v20.i38.13718] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
510 Shum H, Rajdev L. Multimodality management of resectable gastric cancer: A review. World J Gastrointest Oncol 2014; 6(10): 393-402 [PMID: 25320655 DOI: 10.4251/wjgo.v6.i10.393] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
511 Marrelli D, Ferrara F, Giacopuzzi S, Morgagni P, Di Leo A, De Franco L, Pedrazzani C, Saragoni L, De Manzoni G, Roviello F. Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer. Ann Surg Oncol 2017;24:2273-80. [PMID: 28405772 DOI: 10.1245/s10434-017-5857-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
512 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues JJ. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2012;1:CD001964. [PMID: 22258947 DOI: 10.1002/14651858.cd001964.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
513 Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol. 2006;93:394-400. [PMID: 16550575 DOI: 10.1002/jso.20495] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
514 Cady B. Fundamentals of contemporary surgical oncology: biologic principles and the threshold concept govern treatment and outcomes1 1No competing interests declared. Journal of the American College of Surgeons 2001;192:777-92. [DOI: 10.1016/s1072-7515(01)00856-0] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
515 Roviello F, Marrelli D, Morgagni P, de Manzoni G, di Leo A, Vindigni C, Saragoni L, Tomezzoli A, Kurihara H; Italian Research Group for Gastric Cancer. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: A longitudinal multicenter study. Annals of Surgical Oncology 2002;9:894-900. [DOI: 10.1007/bf02557527] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
516 Sierra A, Regueira FM, Hernández-Lizoáin JL, Pardo F, Martínez-Gonzalez MA, A-Cienfuegos J. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol. 2003;10:219-226. [PMID: 12679305 DOI: 10.1245/aso.2003.07.009] [Cited by in Crossref: 67] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
517 Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R. Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: A retrospective cohort study on clinical outcomes. Ann Med Surg (Lond) 2016;6:36-41. [PMID: 27141301 DOI: 10.1016/j.amsu.2016.01.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
518 Lacueva FJ, Calpena R. Gastric cancer recurrence: clues for future approaches to avoiding an old problem. J Clin Gastroenterol 2001;32:3-4. [PMID: 11154165 DOI: 10.1097/00004836-200101000-00002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
519 Weitz J, Jaques DP, Brennan M, Karpeh M. Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer. Ann Surg Oncol. 2004;11:682-689. [PMID: 15231523 DOI: 10.1245/aso.2004.03.048] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
520 Khosravi Shahi P, Díaz Muñoz de la Espada VM, García Alfonso P, Encina García S, Izarzugaza Perón Y, Arranz Cozar JL, Hernández Marín B, Pérez Manga G. Management of gastric adenocarcinoma. Clin Transl Oncol 2007;9:438-42. [PMID: 17652057 DOI: 10.1007/s12094-007-0082-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
521 Gil-rendo A, Hernández-lizoain, Martínez-regueira F, Sierra Martínez A, Rotellar Sastre F, Delgado MC, Azcarate VV, Idoate CP, Álvarez-cienfuegos J. Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer. Clin Transl Oncol 2006;8:354-61. [DOI: 10.1007/s12094-006-0182-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
522 Cady B. THE CHANGING ROLE OF THE SURGICAL ONCOLOGIST. Surgical Clinics of North America 2000;80:459-69. [DOI: 10.1016/s0039-6109(05)70195-x] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
523 Peeters KC, van de Velde CJ. Surgical quality assurance in breast, gastric and rectal cancer. J Surg Oncol. 2003;84:107-112. [PMID: 14598352 DOI: 10.1002/jso.10312] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
524 Chang JS, Choi Y, Shin J, Kim KH, Keum KC, Kim HS, Koom WS, Park EC. Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea. Cancer Res Treat 2018;50:118-28. [PMID: 28279066 DOI: 10.4143/crt.2016.575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
525 Pata G, Solaini L, Roncali S, Pasini M, Ragni F. Impact of obesity on early surgical and oncologic outcomes after total gastrectomy with "over-D1" lymphadenectomy for gastric cancer. World J Surg. 2013;37:1072-1081. [PMID: 23408049 DOI: 10.1007/s00268-013-1942-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
526 Martiniuc A, Dumitrascu T, Ionescu M, Tudor S, Lacatus M, Herlea V, Vasilescu C. Pancreatic Fistula after D1+/D2 Radical Gastrectomy according to the Updated International Study Group of Pancreatic Surgery Criteria: Risk Factors and Clinical Consequences. Experience of Surgeons with High Caseloads in a Single Surgical Center in Eastern Europe. J Gastric Cancer 2021;21:16-29. [PMID: 33854810 DOI: 10.5230/jgc.2021.21.e3] [Reference Citation Analysis]
527 Kim MC, Kim HH, Jung GJ. Surgical outcome of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Eur J Surg Oncol. 2005;31:401-405. [PMID: 15837047 DOI: 10.1016/j.ejso.2004.11.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
528 Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby DA, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. Ann Surg. 2015;262:991-998. [PMID: 25563867 DOI: 10.1097/sla.0000000000001040] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 8.4] [Reference Citation Analysis]
529 Crookes PF. Gastric cancer. Clin Obstet Gynecol 2002;45:892-903. [PMID: 12370631 DOI: 10.1097/00003081-200209000-00036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
530 Alimoglu O, Atak I, Eren T. Robot-assisted laparoscopic (RAL) surgery for gastric cancer. Int J Med Robot 2014;10:257-62. [PMID: 24375986 DOI: 10.1002/rcs.1566] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
531 Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309-315. [PMID: 16574546 DOI: 10.1016/s1470-2045(06)70623-4] [Cited by in Crossref: 424] [Cited by in F6Publishing: 192] [Article Influence: 28.3] [Reference Citation Analysis]
532 Hosch SB, Scheunemann P, Izbicki JR. Minimal residual disease in non-small-cell lung cancer. Semin Surg Oncol 2001;20:278-81. [PMID: 11747269 DOI: 10.1002/ssu.1045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
533 Bringeland E, Wasmuth H, Johnsen G, Johnsen T, Juel I, Mjønes P, Uggen P, Ystgaard B, Grønbech J. Outcomes among patients treated for gastric adenocarcinoma during the last decade: Gastric Cancer in the Last Decade. J Surg Oncol 2013;107:752-7. [DOI: 10.1002/jso.23320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
534 Rhome RM, Ru M, Moshier E, Mazumdar M, Buckstein MH. Stage-matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States. J Surg Oncol 2019;119:737-48. [PMID: 30694524 DOI: 10.1002/jso.25389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
535 Benjamin A, Merkow RP. Importance of Adequate Lymphadenectomy in Gastrointestinal Cancer. Cancer Treat Res 2016;168:331-43. [PMID: 29206381 DOI: 10.1007/978-3-319-34244-3_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
536 Jansen EP, Boot H, Saunders MP, Crosby TD, Dubbelman R, Bartelink H, Verheij M, Cats A. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 2007;69:1424-8. [PMID: 17689023 DOI: 10.1016/j.ijrobp.2007.05.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
537 Higashi T, Nakamura F, Saruki N, Sobue T. Establishing a quality measurement system for cancer care in Japan. Jpn J Clin Oncol 2013;43:225-32. [PMID: 23390306 DOI: 10.1093/jjco/hyt001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
538 Weiss MM, Kuipers EJ, Postma C, Snijders AM, Siccama I, Pinkel D, Westerga J, Meuwissen SG, Albertson DG, Meijer GA. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene. 2003;22:1872-1879. [PMID: 12660823 DOI: 10.1038/sj.onc.1206350] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
539 Katai H, Sano T, Fukagawa T, Shinohara H, Sasako M. Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg. 2003;90:850-853. [PMID: 12854112 DOI: 10.1002/bjs.4106] [Cited by in Crossref: 100] [Cited by in F6Publishing: 86] [Article Influence: 5.6] [Reference Citation Analysis]
540 Bringeland EA, Wasmuth HH, Grønbech JE. Perioperative chemotherapy for resectable gastric cancer – what is the evidence? Scandinavian Journal of Gastroenterology 2017;52:647-53. [DOI: 10.1080/00365521.2017.1293727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
541 Bang YJ. Adjuvant chemotherapy: an option for Asian patients only? Recent Results Cancer Res 2012;196:291-305. [PMID: 23129381 DOI: 10.1007/978-3-642-31629-6_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
542 Kim MC, Choi HJ, Jung GJ, Kim HH. Techniques and complications of laparoscopy-assisted distal gastrectomy (LADG) for gastric cancer. Eur J Surg Oncol. 2007;33:700-705. [PMID: 17399938 DOI: 10.1016/j.ejso.2007.02.018] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
543 Lee WJ, Wang W, Chen TC, Chen JC, Ser KH. Totally laparoscopic radical BII gastrectomy for the treatment of gastric cancer: a comparison with open surgery. Surg Laparosc Endosc Percutan Tech. 2008;18:369-374. [PMID: 18716536 DOI: 10.1097/sle.0b013e31816fdd44] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
544 Agnes A, Biondi A, Laurino A, Persiani R, D'Ugo D. Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment. Updates Surg 2020;72:341-53. [PMID: 32157635 DOI: 10.1007/s13304-020-00736-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
545 Blank S, Bläker H, Schaible A, Lordick F, Grenacher L, Buechler M, Ott K. Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients. Langenbecks Arch Surg 2012;397:45-55. [PMID: 21598045 DOI: 10.1007/s00423-011-0805-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
546 Quero L, Bouchbika Z, Kouto H, Baruch-Hennequin V, Gornet JM, Munoz N, Cojean-Zelek I, Houdart R, Panis Y, Valleur P, Aparicio T, Maylin C, Hennequin C. Postoperative chemotherapy followed by conformal concomitant chemoradiotherapy in high-risk gastric cancer. Int J Radiat Oncol Biol Phys 2012;83:574-80. [PMID: 22099038 DOI: 10.1016/j.ijrobp.2011.07.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
547 Drognitz O, Henne K, Weissenberger C, Bruggmoser G, Göbel H, Hopt UT, Frommhold H, Ruf G. Long-term results after intraoperative radiation therapy for gastric cancer. Int J Radiat Oncol Biol Phys 2008;70:715-21. [PMID: 18164840 DOI: 10.1016/j.ijrobp.2007.07.2331] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
548 Goto H, Tokunaga M, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, Niihara M, Tsubosa Y, Terashima M. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric Cancer. 2013;16:590-595. [PMID: 23179369 DOI: 10.1007/s10120-012-0214-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
549 Arcangeli G, Saracino B, Arcangeli G, Angelini F, Marchetti P, Tirindelli Danesi D. Postoperative adjuvant chemoradiation in completely resected locally advanced gastric cancer. International Journal of Radiation Oncology*Biology*Physics 2002;54:1069-75. [DOI: 10.1016/s0360-3016(02)03026-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
550 Tatsumi Y, Tanigawa N, Nishimura H, Nomura E, Mabuchi H, Matsuki M, Narabayashi I. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10. Gastric Cancer 2006;9:120-8. [DOI: 10.1007/s10120-006-0365-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
551 Ohkura Y, Haruta S, Shindoh J, Tanaka T, Ueno M, Udagawa H. Efficacy of prophylactic splenectomy for proximal advanced gastric cancer invading greater curvature. World J Surg Oncol 2017;15:106. [PMID: 28545537 DOI: 10.1186/s12957-017-1173-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
552 Nakauchi M, Suda K, Kadoya S, Inaba K, Ishida Y, Uyama I. Technical aspects and short- and long-term outcomes of totally laparoscopic total gastrectomy for advanced gastric cancer: a single-institution retrospective study. Surg Endosc. 2016;30:4632-4639. [PMID: 26703126 DOI: 10.1007/s00464-015-4726-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
553 Gilbert SM. Separating surgical quality from causality—Gaining perspective in the debate on lymph node count and extent of lymphadenectomy. Cancer 2008;112:2331-3. [DOI: 10.1002/cncr.23471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
554 Pattison S, Mann GB, Crosthwaite G, Lade S, Mitchell C, Leong T, Busuttil RA, Boussioutas A. Predictors of outcome after surgery for gastric cancer in a Western cohort. ANZ J Surg. 2016;86:469-474. [PMID: 25388659 DOI: 10.1111/ans.12915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
555 Deng J, Sun D, Pan Y, Zhang L, Zhang R, Wang D, Hao X, Liang H. Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis. PLoS One. 2012;7:e43925. [PMID: 22952812 DOI: 10.1371/journal.pone.0043925] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
556 Brenkman HJF, Goense L, Brosens LA, Haj Mohammad N, Vleggaar FP, Ruurda JP, van Hillegersberg R. A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study. Ann Surg Oncol 2017;24:2213-23. [PMID: 28247154 DOI: 10.1245/s10434-017-5815-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
557 Aoyama T, Yoshikawa T. Adjuvant therapy for locally advanced gastric cancer. Surg Today. 2017;47:1295-1302. [PMID: 28251375 DOI: 10.1007/s00595-017-1493-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
558 Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates: High Survival Rates for Asians with Gastric Carcinoma. Cancer 2000;89:1883-92. [DOI: 10.1002/1097-0142(20001101)89:9<1883::aid-cncr3>3.0.co;2-h] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
559 Lambert R, Guilloux A, Oshima A, Pompe-Kirn V, Bray F, Parkin M, Ajiki W, Tsukuma H. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer. 2002;97:811-818. [PMID: 11857360 DOI: 10.1002/ijc.10150] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 3.9] [Reference Citation Analysis]
560 Zhu Y, Zhou Y, Zhang W, Xue L, Li Y, Jiang J, Zhong Y, Wang S, Jiang L. Value of quantitative dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging in predicting extramural venous invasion in locally advanced gastric cancer and prognostic significance. Quant Imaging Med Surg 2021;11:328-40. [PMID: 33392032 DOI: 10.21037/qims-20-246] [Reference Citation Analysis]
561 Michel P, Di Fiore F. [Adjuvant chemotherapy for gastric carcinoma]. Gastroenterol Clin Biol 2006;30:96-101. [PMID: 16514386 DOI: 10.1016/s0399-8320(06)73120-7] [Reference Citation Analysis]
562 Geh JI, Glynne-Jones R, Kwok QS, Banerji U, Livingstone JI, Townsend ER, Harrison RA, Mitchell IC. Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma. Clin Oncol (R Coll Radiol) 2000;12:182-7. [PMID: 10942336 DOI: 10.1053/clon.2000.9147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.0] [Reference Citation Analysis]
563 Curtis JL, Burns RC, Wang L, Mahour GH, Ford HR. Primary gastric tumors of infancy and childhood: 54-year experience at a single institution. Journal of Pediatric Surgery 2008;43:1487-93. [DOI: 10.1016/j.jpedsurg.2007.11.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
564 Douglass HO. Gastric cancer: D2 all over again. Ann Surg Oncol 2003;10:206-7. [PMID: 12679301 DOI: 10.1245/aso.2003.01.015] [Reference Citation Analysis]
565 Lim DH. Postoperative adjuvant radiotherapy for patients with gastric adenocarcinoma. J Gastric Cancer 2012;12:205-9. [PMID: 23346491 DOI: 10.5230/jgc.2012.12.4.205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
566 Krijnen P, den Dulk M, Meershoek-Klein Kranenbarg E, Jansen-Landheer ML, van de Velde CJ. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control. Eur J Surg Oncol. 2009;35:715-720. [PMID: 19144490 DOI: 10.1016/j.ejso.2008.12.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
567 Hartgrink HH, van de Velde CJ, Putter H, Songun I, Tesselaar ME, Kranenbarg EK, de Vries JE, Wils JA, van der Bijl J, van Krieken JH; Cooperating Investigators of The Dutch Gastric Cancer Group. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol. 2004;30:643-649. [PMID: 15256239 DOI: 10.1016/j.ejso.2004.04.013] [Cited by in Crossref: 126] [Cited by in F6Publishing: 114] [Article Influence: 7.4] [Reference Citation Analysis]
568 Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Modern surgery for gastric cancer--Japanese perspective. Scand J Surg 2006;95:232-5. [PMID: 17249270 DOI: 10.1177/145749690609500404] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
569 Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635-648. [PMID: 32861308 DOI: 10.1016/s0140-6736(20)31288-5] [Cited by in Crossref: 162] [Cited by in F6Publishing: 148] [Article Influence: 162.0] [Reference Citation Analysis]
570 Chen XZ, Hu JK, Yang K, Wang L, Lu QC. Short-term evaluation of laparoscopy-assisted distal gastrectomy for predictive early gastric cancer: a meta-analysis of randomized controlled trials. Surg Laparosc Endosc Percutan Tech. 2009;19:277-284. [PMID: 19692873 DOI: 10.1097/sle.0b013e3181b080d3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
571 Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction. Ann Surg Oncol 2007;14:1305-11. [DOI: 10.1245/s10434-006-9309-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
572 Klein Kranenbarg E, Hermans J, van Krieken JH, van de Velde CJ. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer 2001;84:64-71. [PMID: 11139315 DOI: 10.1054/bjoc.2000.1548] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
573 Coburn N, Seevaratnam R, Paszat L, Helyer L, Law C, Swallow C, Cardosa R, Mahar A, Lourenco LG, Dixon M. Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg. 2014;259:102-108. [PMID: 23478525 DOI: 10.1097/sla.0b013e318288dd2b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 4.9] [Reference Citation Analysis]
574 Kim C, Mulder K, Spratlin J. How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer. Oncologist. 2014;19:1046-1055. [PMID: 25142842 DOI: 10.1634/theoncologist.2014-0006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
575 Randle RW, Swords DS, Levine EA, Fino NF, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Pawlik TM, Jin LX, Spolverato G, Schmidt C, Worhunsky D, Cho CS, Maithel SK, Votanopoulos KI. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative. J Surg Oncol 2016;113:750-5. [PMID: 26996496 DOI: 10.1002/jso.24227] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
576 Dicken BJ, Saunders LD, Jhangri GS, de Gara C, Cass C, Andrews S, Hamilton SM. Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol. 2004;11:629-635. [PMID: 15150070 DOI: 10.1245/aso.2004.09.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
577 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2003;CD001964. [PMID: 14583942 DOI: 10.1002/14651858.cd001964.pub2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
578 Kim TH, Park SR, Ryu KW, Kim Y, Bae J, Lee JH, Choi IJ, Kim Y, Kim DY. Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection. International Journal of Radiation Oncology*Biology*Physics 2012;84:e585-92. [DOI: 10.1016/j.ijrobp.2012.07.2378] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
579 Kodera Y. The beginning of a new era: East meets West more comfortably regarding lymphadenectomy for gastric cancer — Japan will finally drop the surgery-alone arm in its pursuit of a multimodal treatment strategy. Gastric Cancer 2007;10:69-74. [DOI: 10.1007/s10120-007-0423-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
580 Fayers PM, Cuschieri A, Fielding J, Craven J, Uscinska B, Freedman LS. Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer 2000;82:213-9. [PMID: 10638992 DOI: 10.1054/bjoc.1999.0902] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
581 Songun I, van de Velde CJ. How does extended lymphadenectomy influence practical care for patients with gastric cancer? Nat Rev Clin Oncol 2009;6:66-7. [DOI: 10.1038/ncponc1300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
582 Mcculloch P. How I do it: D2 gastrectomy. European Journal of Surgical Oncology (EJSO) 2002;28:738-43. [DOI: 10.1053/ejso.2002.1343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
583 Ilson DH. Current Progress in the Adjuvant Treatment of Gastric Cancer. Surgical Oncology Clinics of North America 2017;26:225-39. [DOI: 10.1016/j.soc.2016.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
584 Wilkinson NW, Howe J, Gay G, Patel-Parekh L, Scott-Conner C, Donohue J. Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation. Ann Surg Oncol. 2008;15:1644-1650. [PMID: 18392661 DOI: 10.1245/s10434-008-9877-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
585 Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114-7124. [PMID: 16192595 DOI: 10.1200/jco.2005.14.621] [Cited by in Crossref: 325] [Cited by in F6Publishing: 159] [Article Influence: 20.3] [Reference Citation Analysis]
586 Gretschel S, Bembenek A, Ulmer Ch, Hünerbein M, Markwardt J, Schneider U, Schlag PM. Prediction of gastric cancer lymph node status by sentinel lymph node biopsy and the Maruyama computer model. Eur J Surg Oncol. 2005;31:393-400. [PMID: 15837046 DOI: 10.1016/j.ejso.2004.11.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
587 Cuschieri A. Laparoscopic gastric resection. Surg Clin North Am. 2000;80:1269-1284, viii. [PMID: 10987035 DOI: 10.1016/s0039-6109(05)70224-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
588 Wilson D, Hiller L, Geh JI. Review of second-line chemotherapy for advanced gastric adenocarcinoma. Clin Oncol (R Coll Radiol). 2005;17:81-90. [PMID: 15830569 DOI: 10.1016/j.clon.2004.10.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
589 den Dulk M, Verheij M, Cats A, Jansen EPM, Hartgrink HH, van de Velde CJH. The Essentials of Locoregional Control in the Treatment of Gastric Cancer. Scand J Surg 2006;95:236-42. [DOI: 10.1177/145749690609500405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
590 Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, Klimberg VS, Kusminsky R, Moffat FL Jr, Noyes RD, Beitsch PD. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005;241:48-54. [PMID: 15621990 DOI: 10.1097/01.sla.0000149429.39656.94] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
591 Pultrum BB, van Bastelaar J, Schreurs LMA, van Dullemen HM, Groen H, Nijsten MWN, van Dam GM, Plukker JTHM. Impact of splenectomy on surgical outcome in patients with cancer of the distal esophagus and gastro-esophageal junction. Dis Esophagus 2008;21:334-9. [DOI: 10.1111/j.1442-2050.2007.00762.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
592 Roggin KK, Posner MC. D3 or not D3... that is not the question. Lancet Oncol. 2006;7:279-280. [PMID: 16574543 DOI: 10.1016/s1470-2045(06)70628-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
593 Lee JH, Kim KM, Cheong JH, Noh SH. Current management and future strategies of gastric cancer. Yonsei Med J 2012;53:248-57. [PMID: 22318810 DOI: 10.3349/ymj.2012.53.2.248] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
594 Cabral F, Ramos P, Monteiro C, Casaca R, Pinto I, Abecasis N. Impact of perioperative chemotherapy on postoperative morbidity after gastrectomy for gastric cancer. Cir Esp 2021;99:521-6. [PMID: 33293027 DOI: 10.1016/j.ciresp.2020.09.006] [Reference Citation Analysis]
595 Faria GR, Pinto-de-Sousa J, Preto JR, Sousa HS, Barbosa JA, Costa-Maia J. Three decades of clinical-pathological trends in gastric cancer: prospective data from a Portuguese hospital. Int J Surg. 2013;11:472-476. [PMID: 23602895 DOI: 10.1016/j.ijsu.2013.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
596 Zhu X, Li J. Gastric carcinoma in China: Current status and future perspectives (Review). Oncol Lett 2010;1:407-12. [PMID: 22966316 DOI: 10.3892/ol_00000071] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
597 Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am. 2013;42:337-357. [PMID: 23639644 DOI: 10.1016/j.gtc.2013.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
598 Mafune K. Surgery for Advanced Gastric Cancer. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 271-86. [DOI: 10.1007/4-431-27713-7_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
599 Shridhar R, Dombi GW, Weber J, Hoffe SE, Meredith K, Konski A. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis. Am J Clin Oncol. 2012;35:216-221. [PMID: 21378540 DOI: 10.1097/coc.0b013e31820dbf08] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
600 Deng J, Liang H, Wang D, Sun D, Pan Y, Liu Y. Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today. 2011;41:210-215. [PMID: 21264756 DOI: 10.1007/s00595-009-4251-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 5.8] [Reference Citation Analysis]
601 Cady B. COMMENTARY ON `MULTIDISCIPLINARY APPROACH TO ESOPHAGEAL AND GASTRIC CANCER' BY STEIN ET AL. Surgical Clinics of North America 2000;80:683-6. [DOI: 10.1016/s0039-6109(05)70206-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
602 Taneja C, Cady B. Decreasing role of lymphatic system surgery in surgical oncology. J Surg Oncol 2005;89:61-6. [DOI: 10.1002/jso.20198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
603 Jiang Y, Ajani JA. Multidisciplinary management of gastric cancer. Curr Opin Gastroenterol 2010;26:640-6. [PMID: 20827183 DOI: 10.1097/MOG.0b013e32833efd9b] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
604 Pelc Z, Skórzewska M, Rawicz-Pruszyński K, Polkowski WP. Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment-Oncological and Surgical Perspective. Cancers (Basel) 2021;13:2509. [PMID: 34065596 DOI: 10.3390/cancers13102509] [Reference Citation Analysis]
605 Lamb P, Sivashanmugam T, White M, Irving M, Wayman J, Raimes S. Gastric cancer surgery--a balance of risk and radicality. Ann R Coll Surg Engl 2008;90:235-42. [PMID: 18430340 DOI: 10.1308/003588408X261546] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
606 Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondragón-Sánchez R, Ruiz-Molina JM. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000;7:210-7. [PMID: 10791852 DOI: 10.1007/BF02523656] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
607 Kovoor PA, Hwang J. Treatment of resectable gastric cancer: current standards of care. Expert Rev Anticancer Ther 2009;9:135-42. [PMID: 19105713 DOI: 10.1586/14737140.9.1.135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
608 Ha MH, Choi MG, Sohn TS, Bae JM, Kim S. Prognostic significance of suprapancreatic lymph nodes and its implication on D2 dissection. Medicine (Baltimore) 2018;97:e11092. [PMID: 29924002 DOI: 10.1097/MD.0000000000011092] [Reference Citation Analysis]
609 Hwang SI, Kim HO, Yoo CH, Shin JH, Son BH. Laparoscopic-assisted distal gastrectomy versus open distal gastrectomy for advanced gastric cancer. Surg Endosc 2009;23:1252-8. [PMID: 18855063 DOI: 10.1007/s00464-008-0140-5] [Cited by in Crossref: 116] [Cited by in F6Publishing: 108] [Article Influence: 8.9] [Reference Citation Analysis]
610 Zhang WH, Chen XZ, Liu K, Chen XL, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital. Med Oncol. 2014;31:150. [PMID: 25112468 DOI: 10.1007/s12032-014-0150-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
611 Uyama I, Suda K, Satoh S. Laparoscopic surgery for advanced gastric cancer: current status and future perspectives. J Gastric Cancer. 2013;13:19-25. [PMID: 23610715 DOI: 10.5230/jgc.2013.13.1.19] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
612 Ozmen MM, Zulfikaroglu B, Ozmen F, Moran M, Ozalp N, Seckin S. D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer. Turk J Surg 2021;37:49-58. [PMID: 34585094 DOI: 10.47717/turkjsurg.2020.4931] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
613 Gunji S, Okabe H, Obama K, Sakai Y. Aortoenteric fistula at the site of esophagojejunostomy after laparoscopic total gastrectomy: report of a case. Surg Today 2014;44:2162-6. [DOI: 10.1007/s00595-014-0834-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
614 Brancato S, Miner TJ. Surgical management of gastric cancer: review and consideration for total care of the gastric cancer patient. Curr Treat Options Gastroenterol 2008;11:109-18. [PMID: 18321438 DOI: 10.1007/s11938-008-0023-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
615 Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, Boot H, Putter H, Peeters KC, van de Velde CJ, Verheij M. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;28:2430-2436. [PMID: 20368551 DOI: 10.1200/jco.2009.26.9654] [Cited by in Crossref: 125] [Cited by in F6Publishing: 61] [Article Influence: 11.4] [Reference Citation Analysis]
616 Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K, Okumura S, Yamamichi K, Hioki K. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;9:27-34. [PMID: 11829427 DOI: 10.1245/aso.2002.9.1.27] [Cited by in Crossref: 174] [Cited by in F6Publishing: 177] [Article Influence: 9.2] [Reference Citation Analysis]
617 Cabral F, Ramos P, Monteiro C, Casaca R, Pinto I, Abecasis N. Impact of perioperative chemotherapy on postoperative morbidity after gastrectomy for gastric cancer. Cir Esp (Engl Ed) 2021;99:521-6. [PMID: 34353591 DOI: 10.1016/j.cireng.2021.07.007] [Reference Citation Analysis]
618 Lim DH, Kim DY, Kang MK, Kim YI, Kang WK, Park CK, Kim S, Noh JH, Joh JW, Choi SH, Sohn TS, Heo JS, Park CH, Park JO, Lee JE, Park YJ, Nam HR, Park W, Ahn YC, Huh SJ. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer 2004;91:11-7. [PMID: 15162146 DOI: 10.1038/sj.bjc.6601896] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
619 Haverkamp L, Ruurda JP, Offerhaus GJ, Weijs TJ, van der Sluis PC, van Hillegersberg R. Laparoscopic gastrectomy in Western European patients with advanced gastric cancer. Eur J Surg Oncol 2016;42:110-5. [PMID: 26603678 DOI: 10.1016/j.ejso.2015.09.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
620 Tentes AK, Markakidis SK, Karanikiotis C, Fiska A, Tentes IK, Manolopoulos VG, Dimitriou T. Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer. Langenbecks Arch Surg 2006;391:124-9. [DOI: 10.1007/s00423-006-0022-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
621 Giuliani A, Miccini M, Basso L. Extent of lymphadenectomy and perioperative therapies: Two open issues in gastric cancer. World J Gastroenterol 2014; 20(14): 3889-3904 [PMID: 24744579 DOI: 10.3748/wjg.v20.i14.3889] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
622 Datta J, Lewis RS Jr, Mamtani R, Stripp D, Kelz RR, Drebin JA, Fraker DL, Karakousis GC, Roses RE. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base. Cancer. 2014;120:2855-2865. [PMID: 24854027 DOI: 10.1002/cncr.28780] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
623 Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Wu H. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: Initial results. World J Gastroenterol 2008; 14(29): 4627-4632 [PMID: 18698676 DOI: 10.3748/wjg.14.4627] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
624 Carlomagno C, Matano E, Bianco R, Cimminiello C, Prudente A, Pagliarulo C, Crispo A, Cannella L, DE Stefano A, D'Armiento FP, DE Placido S. Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors. Exp Ther Med 2010;1:611-7. [PMID: 22993584 DOI: 10.3892/etm_00000096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
625 Crehange G, Bonnetain F, Peignaux K, Truc G, Blanchard N, Rat P, Chauffert B, Ghiringhelli F, Maingon P. Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy. Crit Rev Oncol Hematol. 2010;75:235-242. [PMID: 20044267 DOI: 10.1016/j.critrevonc.2009.11.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
626 Obama K, Okabe H, Hosogi H, Tanaka E, Itami A, Sakai Y. Feasibility of laparoscopic gastrectomy with radical lymph node dissection for gastric cancer: from a viewpoint of pancreas-related complications. Surgery. 2011;149:15-21. [PMID: 20627337 DOI: 10.1016/j.surg.2010.04.014] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 4.8] [Reference Citation Analysis]
627 Larsen AC, Holländer C, Duval L, Schønnemann K, Achiam M, Pfeiffer P, Yilmaz MK, Thorlacius-ussing O, Bæksgaard L, Ladekarl M. A Nationwide Retrospective Study of Perioperative Chemotherapy for Gastroesophageal Adenocarcinoma: Tolerability, Outcome, and Prognostic Factors. Ann Surg Oncol 2015;22:1540-7. [DOI: 10.1245/s10434-014-4127-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
628 Shah MA. Recent developments in the treatment of gastric carcinoma. Curr Oncol Rep 2002;4:193-201. [DOI: 10.1007/s11912-002-0016-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
629 Zhang Y, Tian S. Does D2 plus para-aortic nodal dissection surgery offer a better survival outcome compared to D2 surgery only for gastric cancer consistently? A definite result based on a hospital population of nearly two decades. Scand J Surg. 2013;102:251-257. [PMID: 24056132 DOI: 10.1177/1457496913491343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
630 Guzman EA, Pigazzi A, Lee B, Soriano PA, Nelson RA, Benjamin Paz I, Trisal V, Kim J, Ellenhorn JD. Totally laparoscopic gastric resection with extended lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2009;16:2218-2223. [PMID: 19444523 DOI: 10.1245/s10434-009-0508-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
631 Snyder RA, Castaldo ET, Bailey CE, Phillips SE, Chakravarthy AB, Merchant NB. Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy. Int J Surg Oncol. 2012;2012:307670. [PMID: 22778937 DOI: 10.1155/2012/307670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
632 Cheong O, Kim BS, Yook JH, Oh ST, Park YK, Ryu SY. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer. J Surg Oncol 2008;98:500-4. [PMID: 18770520 DOI: 10.1002/jso.21137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
633 Shu P, Sun X, Liu F, Fang Y, Shen K, Sun Y, Qin J, Qin X. Pattern of No. 12a lymph node metastasis in gastric cancer. Chin J Cancer Res 2021;33:61-8. [PMID: 33707929 DOI: 10.21147/j.issn.1000-9604.2021.01.07] [Reference Citation Analysis]
634 Brooks GA, Enzinger PC, Fuchs CS. Adjuvant therapy for gastric cancer: revisiting the past to clarify the future. J Clin Oncol. 2012;30:2297-2299. [PMID: 22585690 DOI: 10.1200/jco.2012.42.4069] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
635 Uslu A, Zengel B, İlhan E, Aykas A, Şimşek C, Üreyen O, Duran A, Okut G. Survival outcomes after D1 and D2 lymphadenectomy with R0 resection in stage II-III gastric cancer: Longitudinal follow-up in a single center. Turk J Surg 2018;34:125-30. [PMID: 30023977 DOI: 10.5152/turkjsurg.2018.3846] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
636 Bouchbika Z, Quero L, Kouto H, Hennequin-baruch V, Gornet J, Munoz N, Cojean-zelek I, Houdart R, Panis Y, Valleur P, Sergent G, Maylin C, Hennequin C. Chimiothérapie adjuvante suivie d’une chimioradiothérapie conformationnelle dans les cancers de l’estomac. Cancer/Radiothérapie 2008;12:775-80. [DOI: 10.1016/j.canrad.2008.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
637 Lui SA, Tan WB, Tai BC, Yong WP, Mu YS, Ti TK, Shabbir A, So J. Predictors of survival outcome following radical gastrectomy for gastric cancer. ANZ J Surg 2019;89:84-9. [PMID: 30690932 DOI: 10.1111/ans.15011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
638 Correia T, Amaro P, Sofia C. Tratamento de deiscência cirúrgica grave com sistema «Over-the-scope clip». GE Jornal Português de Gastrenterologia 2013;20:261-5. [DOI: 10.1016/j.jpg.2013.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
639 Briasoulis E, Liakakos T, Dova L, Fatouros M, Tsekeris P, Roukos DH, Kappas AM. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Expert Rev Anticancer Ther 2006;6:931-9. [PMID: 16761937 DOI: 10.1586/14737140.6.6.931] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
640 Mou TY, Hu YF, Yu J, Liu H, Wang YN, Li GX. Laparoscopic splenic hilum lymph node dissection for advanced proximal gastric cancer: A modified approach for pancreas- and spleen-preserving total gastrectomy. World J Gastroenterol 2013; 19(30): 4992-4999 [PMID: 23946606 DOI: 10.3748/wjg.v19.i30.4992] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
641 Yoshikawa T, Tsuburaya A, Hirabayashi N, Yoshida K, Nagata N, Kodera Y, Takahashi N, Oba K, Kimura M, Ishikura S, Miyashita Y, Sakamoto J. A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma. Cancer Chemother Pharmacol 2009;64:1071-7. [PMID: 19283353 DOI: 10.1007/s00280-009-0963-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
642 Ajani JA. Operate on My Stomach Cancer? Oh, No—Not You, or Not Yet! JCO 2004;22:1763-4. [DOI: 10.1200/jco.2004.99.277] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
643 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
644 Menges M. Gastric cancer: Where is the place for the surgeon, the oncologist and the endoscopist today? World J Gastrointest Oncol 2011; 3(1): 10-13 [PMID: 21267398 DOI: 10.4251/wjgo.v3.i1.10] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
645 Degiuli M, Sasako M, Ponti A, Vendrame A, Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G, Morino M; Italian Gastric Cancer Study Group. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 2014;101:23-31. [PMID: 24375296 DOI: 10.1002/bjs.9345] [Cited by in Crossref: 159] [Cited by in F6Publishing: 148] [Article Influence: 22.7] [Reference Citation Analysis]
646 Markar SR, Karthikesalingam A, Jackson D, Hanna GB. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East. Ann Surg Oncol. 2013;20:2328-2338. [PMID: 23340695 DOI: 10.1245/s10434-012-2862-9] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
647 Liu XX, Jiang ZW, Chen P, Zhao Y, Pan HF, Li JS. Full robot-assisted gastrectomy with intracorporeal robot-sewn anastomosis produces satisfying outcomes. World J Gastroenterol 2013; 19(38): 6427-6437 [PMID: 24151361 DOI: 10.3748/wjg.v19.i38.6427] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
648 Kim TU, Kim S, Lee NK, Kim HJ, Han GJ, Lee JW, Baek HJ, Jeon TY, Kim HS, Park DY. Prognostic Value of Computed Tomography–Detected Extramural Venous Invasion to Predict Disease-Free Survival in Patients With Gastric Cancer: . Journal of Computer Assisted Tomography 2017;41:430-6. [DOI: 10.1097/rct.0000000000000543] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
649 Shi Y, Zhou Y. The role of surgery in the treatment of gastric cancer. J Surg Oncol. 2010;101:687-692. [PMID: 20512944 DOI: 10.1002/jso.21455] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
650 Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 2017;10:149. [PMID: 28810883 DOI: 10.1186/s13045-017-0517-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
651 Saito H, Kono Y, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Therapeutic Value of Lymph Node Dissection Along the Superior Mesenteric Vein and the Posterior Surface of the Pancreatic Head in Gastric Cancer Located in the Lower Third of the Stomach. Yonago Acta Med. 2018;61:175-181. [PMID: 30275748 DOI: 10.33160/yam.2018.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
652 Meyer HJ. The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur J Surg Oncol. 2005;31:595-604. [PMID: 15919174 DOI: 10.1016/j.ejso.2005.03.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
653 Clark CJ, Thirlby RC, Picozzi V, Schembre DB, Cummings FP, Lin E. Current problems in surgery: gastric cancer. Curr Probl Surg. 2006;43:566-670. [PMID: 17000267 DOI: 10.1067/j.cpsurg.2006.06.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
654 Liu X, Xu P, Qiu H, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X. Preoperative Nutritional Deficiency Is a Useful Predictor of Postoperative Outcome in Patients Undergoing Curative Resection for Gastric Cancer. Transl Oncol 2016;9:482-8. [PMID: 27788388 DOI: 10.1016/j.tranon.2016.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
655 Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol 2016; 22(10): 2875-2893 [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 51] [Article Influence: 11.4] [Reference Citation Analysis]
656 Sakuramoto S, Yamashita K, Watanabe M. Appropriateness of splenectomy for advanced cancer located in the upper third of the stomach. Surg Endosc 2010;24:1219-20. [DOI: 10.1007/s00464-009-0710-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
657 Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol. 2002;9:394-400. [PMID: 11986192 DOI: 10.1007/bf02573875] [Cited by in Crossref: 112] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
658 Loh J, Maclellan S, Okrainec A, Mackay H, Jacks L, Sykes J, Kassam Z, Conrad T, Khalili I, Ringash J. Gastric cancer recurrence after resection and adjuvant chemoradiation. J Radiat Oncol 2015;4:79-85. [DOI: 10.1007/s13566-015-0183-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
659 Lacueva J, Gallego J, Díaz-González JA. Updating controversies on the multidisciplinary management of gastric cancer. Clin Transl Oncol. 2010;12:677-685. [PMID: 20947482 DOI: 10.1007/s12094-010-0577-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
660 Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg 2014;18:505-11. [PMID: 24443204 DOI: 10.1007/s11605-014-2455-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
661 Yura M, Yoshikawa T, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T. The Therapeutic Survival Benefit of Splenic Hilar Nodal Dissection for Advanced Proximal Gastric Cancer Invading the Greater Curvature. Ann Surg Oncol 2019;26:829-35. [DOI: 10.1245/s10434-018-07122-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
662 Chandran S, Vaughan R, Efthymiou M, Sia J, Hamilton C. A pilot study of EUS-guided fiducial insertion for the multidisciplinary management of gastric cancer. Endosc Int Open 2014;2:E153-9. [PMID: 26134962 DOI: 10.1055/s-0034-1377523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
663 Pang W, Lou N, Jin C, Hu C, Arvine C, Zhu G, Shen X. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol 2016;28:493-502. [PMID: 26854795 DOI: 10.1097/MEG.0000000000000563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
664 Coccolini F, Montori G, Ceresoli M, Cima S, Valli MC, Nita GE, Heyer A, Catena F, Ansaloni L. Advanced gastric cancer: What we know and what we still have to learn. World J Gastroenterol 2016; 22(3): 1139-1159 [PMID: 26811653 DOI: 10.3748/wjg.v22.i3.1139] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
665 Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg. 2004;91:283-287. [PMID: 14991627 DOI: 10.1002/bjs.4433] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 6.5] [Reference Citation Analysis]
666 Ji X, Bu ZD, Li ZY, Wu AW, Zhang LH, Zhang J, Wu XJ, Zong XL, Li SX, Shan F, Jia ZY, Ji JF. Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients. BMC Cancer 2017;17:558. [PMID: 28830455 DOI: 10.1186/s12885-017-3544-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
667 Sastre J, García-Saenz JA, Díaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol 2006; 12(2): 204-213 [PMID: 16482619 DOI: 10.3748/wjg.v12.i2.204] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 58] [Article Influence: 3.9] [Reference Citation Analysis]
668 Schwarz RE. Spleen-preserving splenic hilar lymphadenectomy at the time of gastrectomy for cancer: technical feasibility and early results. J Surg Oncol. 2002;79:73-76. [PMID: 11754382 DOI: 10.1002/jso.10036] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
669 Ferri L. Extended Lymphadenectomy in Gastric Cancer Is Crucial. World J Surg 2013;37:1768-72. [DOI: 10.1007/s00268-013-2069-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
670 Misleh JG, Santoro P, Strasser JF, Bennett JJ. Multidisciplinary Management of Gastric Cancer. Surgical Oncology Clinics of North America 2013;22:247-64. [DOI: 10.1016/j.soc.2012.12.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
671 Faiz Z, Hayashi T, Yoshikawa T. Lymph node dissection for gastric cancer: Establishment of D2 and the current position of splenectomy in Europe and Japan. Eur J Surg Oncol 2021;47:2233-6. [PMID: 33910779 DOI: 10.1016/j.ejso.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
672 Phillips JD, Nagle AP, Soper NJ. Laparoscopic gastrectomy for cancer. Surg Oncol Clin N Am 2013;22:39-57, v-vi. [PMID: 23158084 DOI: 10.1016/j.soc.2012.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
673 Kim S, Kim JS, Jeong HY, Noh SM, Kim KW, Cho MJ. Retrospective analysis of treatment outcomes after postoperative chemoradiotherapy in advanced gastric cancer. Radiat Oncol J. 2011;29:252-259. [PMID: 22984678 DOI: 10.3857/roj.2011.29.4.252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
674 Liu YY, Fang WL, Wang F, Hsu JT, Tsai CY, Liu KH, Yeh CN, Chen TC, Wu RC, Chiu CT, Yeh TS. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit. Oncologist 2017;22:97-106. [PMID: 27789777 DOI: 10.1634/theoncologist.2016-0239] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
675 Moslim MA, Minarich MJ, Deng M, Handorf E, Greco SH, Reddy SS, Farma JM. Treatment at an Academic Cancer Center Confers Better Survival by Stage for Signet-Ring Cell and Non-signet-Ring Cell Gastric Cancer. Ann Surg Oncol 2021;28:4423-32. [PMID: 33393048 DOI: 10.1245/s10434-020-09424-3] [Reference Citation Analysis]
676 Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D’Ugo D. R0 resection in the treatment of gastric cancer: Room for improvement. World J Gastroenterol 2010; 16(27): 3358-3370 [PMID: 20632437 DOI: 10.3748/wjg.v16.i27.3358] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
677 Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Koh M, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanazaki K, Mori M, Doki Y, Naka T. Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer. Oncotarget 2018;9:32917-28. [PMID: 30250639 DOI: 10.18632/oncotarget.25952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
678 Persiani R, Rausei S, Antonacci V, Biondi A, Casella F, Ciccoritti L, D’ugo D. Metastatic Lymph Node Ratio: A New Staging System for Gastric Cancer. World J Surg 2009;33:2106-11. [DOI: 10.1007/s00268-009-0157-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
679 Calero A, Escrig-Sos J, Mingol F, Arroyo A, Martinez-Ramos D, de Juan M, Salvador-Sanchis JL, Garcia-Granero E, Calpena R, Lacueva FJ. Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas. J Gastrointest Surg 2015;19:813-20. [PMID: 25560183 DOI: 10.1007/s11605-014-2728-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
680 Mirkin KA, Hollenbeak CS, Wong J. Greater Lymph Node Retrieval Improves Survival in Node-Negative Resected Gastric Cancer in the United States. J Gastric Cancer 2017;17:306-18. [PMID: 29302371 DOI: 10.5230/jgc.2017.17.e35] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
681 Wang W, Zhang X, Shen C, Zhi X, Wang B, Xu Z. Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis. PLoS One. 2014;9:e88753. [PMID: 24558421 DOI: 10.1371/journal.pone.0088753] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [